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Background: Unawareness of memory functioning is a key symptom of Alzheimer’s 
disease and dementia that has been demonstrated to be related to a number of important 
factors for the person with dementia (PwD) and their family caregivers including quality 
of life and depression. Understanding more about how awareness relates to these factors 
will help inform how PwD and their caregivers are best supported.    
Objective: A meta-analysis was conducted in order to examine the relationship between 
Awareness and depression in dementia. An empirical study was conducted to examine the 
contribution awareness provides to explaining PWDs’ Quality of Life (QoL). PwD have 
been found to be aware of factors that affect their caregiver and so caregiver wellbeing 
and quality of life and the quality of the caregiving relationship were also investigated as 
well as more established predictors of quality of life for PwD. Both PwD self-ratings and 
caregiver ratings of the PwD they care for of QoL were examined as they have been shown 
to be affected by different factors.  
Method: Meta-analysis: A search of electronic databases Psycinfo, Embase and Medline 
was conducted. A meta-analysis of correlations was undertaken examining the 
relationship between awareness and depression in dementia. Empirical study: 27 PwD and 
their caregivers were recruited. In order to assess the research aims the PwD completed 
measures of: Quality of life (Quality Of Life-Alzheimer’s Disease scale), awareness of 
memory functioning (Memory Awareness Rating Scale-Adjusted), cognitive functioning 
(Addenbrooke’s Cognitive Exam-R), depression and anxiety (Hospital Anxiety and 
Depression Scale). The caregiver completed measures of: PwD Quality of life (Quality 
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Of Life-Alzheimer’s Disease scale proxy), Memory Functioning Scale (from MARSA), 
self-ratings of depression and anxiety (Hospital Anxiety and Depression Scale), activities 
of daily living (Disability Assessment in Dementia), Neuropsychiatric symptoms 
(Neuropsychiatric symptoms inventory-Questionnaire), caregiver burden (Zarit Burden 
Inventory), and rating of relationship quality with PwD (Burns Relationship Satisfaction 
Scale).   
Results: Meta-analysis: Thirty-one studies were identified. A small association was 
found between awareness and depression with substantial amount of heterogeneity (-
0.23). Analysing the studies that excluded major depression demonstrated that mild 
depression had a moderate negative relationship with awareness (-0.42). Subgroup 
analysis showed that the different measures of awareness used seemed to suggest different 
effects with depression for different measures.  Empirical study: Awareness was not found 
to predict PwD rated or caregiver rated QoL. No caregiver variables predicted PwD QoL. 
Depression and neuropsychiatric symptoms predicted PwD QoL. Caregiver rated QoL 
was predicted by activities of daily living and caregiver rated quality of caregiving 
relationship. 
Conclusions: Meta-analysis: The effect between mild depression and lack of awareness 
but not major depression supports the assertion that unawareness is a psychological 
response to decline in memory functioning in dementia. Neither depression nor awareness 
appear to be unitary constructs in PwD. Empirical study: Awareness not related to PwD 
QoL. The quality of caregiving relationship is important to QoL in a dementia context. 
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Background: Unawareness of cognitive impairment is considered to be a defining 
symptom of people with Alzheimer’s disease (AD). Unawareness and depression have 
been demonstrated to be important factors in determining quality of life for people with 
AD and their caregivers. The evidence in the literature for the relationship between 
awareness and depression in people with AD has been inconsistent. Some studies found 
a negative association while others found no association. It has also been argued that mild 
depression has a different relationship with awareness to major depression. There is also 
great variance in how awareness is conceptualised and measured.  
Objectives: The purpose of this study was to determine the whether there is an effect 
between awareness of cognitive functioning and depression in people with AD and to 
determine whether level of depression or measure of awareness used affects that 
relationship.       
Method: A search of electronic databases Psycinfo, Embase and Medline was conducted. 
A meta-analysis of correlations was undertaken examining the relationship between 
awareness and depression in dementia. 
Results: Thirty-one studies were identified. A small association was found between 
awareness of cognitive functioning and depression with substantial amount of 
heterogeneity (-0.23). Analysing the studies that excluded major depression demonstrated 
that mild depression had a moderate negative relationship with awareness (-0.42). 
Subgroup analysis of the different measures of awareness used in the sample seemed to 
suggest that different effects with depression were present for different measures.   
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Conclusions: The effect between mild depression and lack of awareness but not major 
depression supports the assertion that unawareness is a psychological response to decline 
in memory functioning in dementia. Neither depression nor awareness appear to be 
unitary constructs in PwD. 






Alzheimer’s disease (AD) is a disorder that is estimated to affect 5-7% of the population 
over 60 years old in most regions of the world. The number of people with AD is 
predicted to double by 2030 (Prince et al., 2013). The most recent estimate of the AD 
population in the UK was that there are 670,000 people aged over 65 with AD 
(2011)(Matthews et al., 2013). The burden of AD on community and inpatient settings is 
substantial and there are many areas where our understanding is lacking. Awareness of 
memory functioning and depression have been shown to be key factors in determining 
Quality of life in AD (Conde-Sala et al., 2013; Trigg et al., 2011) and it is important to 
understand their relationship in order to provide the best support for people with AD and 









There are multiple terms to describe lack of awareness in AD including Anosognosia 
(meaning lack of knowledge of disease) (Babinsky., 1914), unawareness, self-awareness, 
insight,  and denial (Aalten et al., 2005a). Clare et al. (2012b) defined awareness as 
“reasonable or realistic perception or appraisal of a given aspect of one’s situation, 
functioning or performance, or the resulting implications, which may be expressed 
implicitly or explicitly.” Currently there is no agreed upon definition of awareness and 
precise definitions of awareness vary which make comparing research studies problematic 
and these definitions can vary (Aalten et al., 2005a).  
Awareness in AD is variable in its presentation and severity with some people completely 
unaware of their difficulties while others simply minimise their difficulties and dismiss 
them as normal aging (Mograbi and Morris, 2014). Picton & Stuss (1994) suggested that 
awareness ranges across different levels from basic physiological arousal through to 
elements of self-perception in complex social contexts. Clare et al. (2011) built on this 
describing a multifactorial model acknowledging the contribution and interaction of 
organic and psychosocial factors with four levels of awareness; sensory registration (basic 
awareness of environment), performance monitoring (ability to monitor performance on 
a certain task), evaluative judgment (evaluation of ability in a specific domain such as 
memory), and meta-representation (reflection on changes of a person’s situation and their 
impact). It seems apparent that there are different constructs that make up awareness; 
however, it can be difficult to differentiate the neurologically based impaired awareness 
that is part of the disease process and the psychological response to changes in functioning 
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that manifest as denial or avoidant coping. Awareness is also likely to be affected by other 
factors such as depression, personality changes and psychotic experiences, consequences 
and the wider socio-cultural context (Clare et al., 2005a). Unawareness can present a 
significant challenge to care givers affecting decisions of capacity, treatment, care 
management and risk (Starkstein et al., 2007). There is evidence to suggest that people 
with AD who are more aware report a decline in quality of life more than those who are 
more unaware (Conde-Sala et al., 2014; Hurt et al., 2010; Trigg et al., 2011).  
Most often in the literature when awareness is described it is referring to evaluative 
judgements regarding awareness of cognitive and memory functioning. However, some 
studies also discuss “awareness” when examining awareness of functioning of activities 
of daily living or a combination of awareness of cognitive functioning and activity 
functioning. There are also studies that examine the performance monitoring (e.g. 
awareness of performance on a task they just completed) and meta-representation levels 
of awareness (e.g. awareness of progression of their diagnosis). As there is no consensus 
in the literature on the definition of awareness this study will use it as a universal term to 
encompass the concepts described above.  Using a more focussed definition would mean 
that the review would only be able to relate to proportion of the literature.   
 
Awareness in Dementia 
 
Lack of awareness in AD is considered to be a defining symptom of the illness  and has 
been shown to occur more frequently in AD than in other  forms of dementia 
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(DeBettignies et al., 1990). It is thought that this higher prevalence is accounted for to an 
extent by the neurobiological changes that occur with the disorder. Psychological and 
social factors also provide further explanation (Mograbi and Morris, 2014). Lack of 
awareness in AD most commonly takes the form of a person overestimating their current 
abilities although people who underestimate their abilities would also be considered to 
lack awareness. The majority of studies examining awareness have examined exclusively 
late onset AD patients and so it can be difficult to make generalisations regarding other 
dementia aetiologies  such as vascular dementia (Aalten et al., 2005b). There are a small 
number of studies that include vascular dementia participants along with AD and have 
reported similar levels of awareness (Verhey et al., 1993; Zanetti et al., 1999). Young 
onset dementia has been demonstrated to have a different relationship with awareness to 
late onset. In a study comparing awareness in young onset and late onset AD it was found 
that unawareness seems to be more of a characteristic of late onset AD as it has been found 
that  people with late onset AD are more than double the odds of being unaware of their 
cognitive deficits compared to the people with young onset AD (van Vliet et al., 2012).  
It has also been demonstrated that unawareness is correlated with age of onset with 
increase in age of onset being associated with more severe unawareness. It was suggested 
that the differences found in unawareness may be associated to the neurological 
differences between young and late onset  AD (Kashiwa et al., 2005).   
Awareness has been shown to present differently in People with Parkinson’s disease 
compared to people with AD as they have been demonstrated have relatively preserved 
awareness in regards to memory functioning However, it was found that when memory 
impairment was present the participants were more likely to overestimate their abilities. 
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(Lehrner et al., 2015; Seltzer et al., 2001; Sitek et al., 2011).  It was also found that 
participants who reported more symptoms of depression were also more likely to 
overestimate their memory functioning.  
 
Measurement of Awareness 
 
There are three main categories  of assessments that have been used to examine awareness 
in AD: Clinician rating, discrepancy ratings between patients and caregiver informants or 
clinician ratings, and discrepancy ratings between predicted performance and actual 
performance (Starkstein, 2014). The object of focus for assessing awareness is variable 
across the different measures and types of measures with some focussing on memory 
functioning and others on broader domains of cognitive functioning and activities of daily 
living. Some methods place more emphasis on perceived current functioning, while others 
on perception of impact of difficulties and progression (Clare et al., 2005a). Each method 
also has its own assumptions.  
 
There are a range of Clinician rating methods for assessing patient’s awareness. A semi-
structured or standard interview with the patient and sometimes an informant is often used 
where they are rated into a category of awareness ranging from a dichotomous 
classification to a point on a Likert scale depending on the measures used (Clare et al., 
2005a). The advantages of this method are that it is quick and there is potential for answers 
to be explored in more depth (Sevush and Leve, 1993). Clinician ratings methods make 
18 
 
the assumption that awareness is a symptom that can be reliably assessed in an interview 
which is made more difficult by the lack of standardised diagnostic criteria and the 
unknown validity and reliability of the measures used (Starkstein, 2014).  Clare et al. 
(2005) state that, while global ratings from clinicians are practical, they can miss 
variations within participants in different domains and these ratings will be affected by 
the clinician; the factors they see as most relevant how they interpret the patient’s account, 
and their expectations is considered normal awareness. 
Awareness has most often been operationalised in terms of a discrepancy between the 
individual’s explicit responses and some kind of standard. The most common type being 
comparing self-report of patient’s awareness against that of an informant who knows them 
well and calculating the discrepancy between the two ratings as the level of awareness 
(Clare et al., 2005a). Therefore any deviation from the informant is seen to reflect a loss 
of awareness.  A positive score reflects that the PwD is overestimating their ability and a 
negative score reflects that they are underestimating. This method assumes that the 
informant is able to provide an accurate, objective and valid rating and caregiver ratings 
are known to be affected by factors such as depression or burden which can influence 
ratings (Starkstein, 2014).  There seems to be conflicting evidence to as to the extent that 
this is the case. There are some studies where caregiver ratings have been demonstrated 
to be accurate; Clare et al. (2002) found that caregiver ratings to be comparatively more 
accurate than patient ratings but their accuracy overall was somewhat low. Whereas Snow 
et al. (2004) found that they were significantly associated with clinician ratings and 
Starkstein et al. (2006) showed that caregiver assessments of deficits are associated with 
Mini mental state exam (MMSE), a measure of symptom severity. Another limitation of 
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P/I discrepancy ratings is that using a simple discrepancy score also weights the overall 
score more heavily towards the caregiver rating (Clare et al., 2010).    
A less widely used method is the prediction of performance discrepancy which is based 
on patient’s perception of their performance on a given neuropsychological task and is 
scored as the difference between patient’s estimation of performance and score on the test.  
These methods use standardised assessments with strong psychometric properties and 
self-report measures that generally have established validity and reliability (Clare et al., 
2005a). The ecological validity of this procedure is unknown as patients may minimise 
functional problems while acknowledging performing poorly on a cognitive test and vice 
versa. Duke et al. (2002) found that there were only modest correlations between 
performance based methods of measuring awareness and a questionnaire-based method 
which would seem to suggest that using different methods of measurement may examine 
different aspects of awareness. This would be consistent with Clare and colleagues (2011) 
four level model as one is a task of performance monitoring and the other an evaluative 
judgement.  A limitation of this method is that awareness tends more to be about 
functional problems rather than neuropsychological test performance (Starkstein, 2014). 
An additional difficulty with comparing self-ratings of everyday functioning and 
performance on cognitive tests is that that the self-rating and performance measures may 
not be closely related, thus giving disproportionately high discrepancy values (Clare et 
al., 2005a).  
Other methods of assessing have been used to evaluate awareness including self-report 
questionnaires and vignettes (Clare et al. 2012a). There is no definitive method to assess 
awareness; there are strengths and shortcomings to each procedure.  Starkstein (2014) 
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argues that the best assessment is by an experienced clinician with an informant providing 
extra information. Clare et al. (2005) states that, in order to overcome the limitations of 
the methods used, the first step is to acknowledge that different measures may be 
evaluating different constructs and to be precise in how the assessment of awareness is 
described (e.g. measure of awareness of memory functioning).  
 
Depression in AD 
 
The causes of depression in AD has been shown to be complex, with family and personal 
history of depression, genetic factors, genetics, a common neurobiological basis with AD 
pathology, and a psychological reaction to changes related to the illness, all considered to 
be factors in its development (Mograbi and Morris, 2014). The frequency of depression 
in awareness is estimated to be present in the range of 20-40% of cross-sectional samples, 
this large range is thought to be dependent on a number of factors such as severity of 
dementia, sample bias, and the variety of differing assessments used to measure 
depression (Starkstein, 2014). Nakaaki et al. (2008) state that older adults with depression 
often report subjective memory complaints when there is no objective evidence of a 
memory problem so it seems consistent that older adults with mild AD may also be more 
aware of their memory disturbances than AD patients without depression. There is 
evidence to suggest that major and minor depression are distinct disorders in AD, with 
major depression being associated with more severe psychopathological and neurological 




Awareness and Depression 
 
There have been three narrative reviews which have examined the relationship between 
awareness and depression (Aalten et al., 2005a; Mograbi and Morris, 2014; Starkstein, 
2014). However, these reviews have investigated depression as one of multiple clinical 
correlates and only described the literature rather than systematically evaluate it or 
conduct a meta-analysis. All the reviews agreed that when an association was found that 
the literature suggested that higher awareness is associated with more depression. 
However, there are a number of studies that have failed to find an association between 
depression and awareness (Cummings et al., 1995; DeBettignies et al., 1990; Verhey et 
al., 1993; Vogel et al., 2010). There are also studies that found that the association was 
only between mild depression and awareness but not major depression (Migliorelli et al., 
1995b; Starkstein et al., 1997; Troisi et al., 1996). It has been suggested that this 
association may be indicative of an emotional reaction to awareness of deficits rather than 
experiencing some of the somatic symptoms associated with depression such as fatigue 
and slowness (Troisi et al., 1996). Nakaaki et al. (2008) found that patients with AD and 
depression may estimate their memory ability either more accurately or more negatively 
(underestimate their functioning) than patients without depression. The reason for this 
inconsistency between studies may be because different conceptual models of awareness 
and different assessment methods are being used as well as there being heterogeneity in 
sample size and level of disease severity between the studies (Aalten et al., 2005a). 
Mograbi & Morris (2014) concur stating that different findings may in part be due to 
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awareness not being a unitary concept and the associations found with depression may be 
dependent upon the specific type of awareness measured; for example, the association 
with mood and awareness of cognitive deficits may well be different to the association 
found with functional awareness. Therefore the use of complementary measures of 
awareness would help discern which constructs and facets of these two phenomena are 
related.  
The primary aim of this study is to provide a meta-analysis of the association between 
awareness of cognitive functioning in AD and depression.  The secondary aims are to; 1) 
Examine whether the relationship between the two variables is different depending on the 
level of depression as there is some suggestion in the literature that mild depression is 
more strongly associated than moderate depression 2) Examine whether how awareness 
is measured affects its relationship to depression, as although it is often treated as a unitary 
construct there is great variability in the literature as to how it is operationalised and 
defined.  
Hypothesis 1: There will be at least a small effect between depression and awareness of 
cognitive functioning in AD. 
Hypothesis 2: Mild depressive symptoms will have a stronger negative relationship to 
unawareness than moderate depression.  
 
Hypothesis 3: The variance in effects measured by the studies will be accounted for by 









The inclusion criteria were that the studies had to be 1) published in a peer reviewed 
journal in English, 2) the primary group of participants being investigated are people with 
probable Alzheimer’s disease, 3) include an assessment of depression either from a 
standardised and validated rating scale or established diagnostic criterion, 4) include an 
assessment of awareness that are not items or a subscale from another measure (e.g. a 
single question about insight or using the awareness related questions from the Geriatric 
Depression Scale) or that are unstructured clinical judgement, 5) provide appropriate 
statistics that can be converted into an effect size for the purposes of meta-analysis, and 
6) the sample in the paper is independent from other papers included in the analysis.  
Awareness was broadly defined “as appraisal of one’s deficits, functioning, situation” in 
line with the definition by Clare et al. (2012a). The study included any paper that measured 
depression using a standardised measure or diagnostic criteria. This study is primarily 
concerned with examining papers with participants who have received a diagnosis of 
Alzheimer’s disease, papers primarily examining other forms of cognitive impairment 
were not included as they have been shown to have a different relationship to awareness. 
Alzheimer’s disease or dementia was defined as meeting criteria for ICD, DSM, or the 
National Institute of Neurological and Communicative Disorders and Stroke criteria and 
the Alzheimer’s Disease and Related Disorders Association criteria for probable 







The electronic databases EMBASE, Medline and Psycinfo were searched to the beginning 
of February 2016 with the search terms: Alzheimer* OR Dementia AND Depression OR 
“low mood” OR “affective disorder” AND Anosognosia OR Insight OR Awareness OR 
Self-Awareness. The search was conducted for papers published in peer reviewed journals 
in English only. After duplicates were removed using the inbuilt function in the search 
engine, keywords and titles were screened. Then abstracts were reviewed of the remaining 
texts. The full texts of the remaining articles were subsequently screened and additional 
articles were added for screening through investigating previous relevant reviews and the 
bibliographies of screened articles.  Papers that did not meet the inclusion criteria or did 
not have any data that could be used in the meta-analysis were excluded (Appendix A.). 




Papers found from other 
sources. N=9 
Articles remaining. N=1149 
Duplicates removed. N=568 
Titles and Keywords reviewed 
removed. N=1012 
Full texts reviewed and excluded (n=29) 
Same sample as another included study n=6 
Not published in English n=1 
No data reported n=6 
Unable to obtain article n=1 
Awareness measure does not meet 
inclusion criteria n=10 
Depression measure does not meet 
inclusion criteria n=2 
Depression not assessed=1 
Unable to compute effect size n=2 
Association not assessed n=1 
Articles remaining. N=31 
Search of Embase, Medline 
and Psycinfo databases using 
specified search terms. 
N=1717 
Abstracts reviewed. Removed. 
N=86 
Articles remaining. N=137 
Articles remaining. N=51 
Articles remaining. N=60 






The data extraction of study details was undertaken by the author and an independent co-
rater using a pre-specified extraction form. Any disagreements were resolved through 
discussion.  
As the majority of the data was correlational in nature, the different measures or 
coefficients were converted to Pearson’s r. In the case of spearman’s rho calculations they 
were converted into approximate Pearson’s r following Rupinski & Dunlap (1996).  
Standardised coefficients from multiple regression analyses have been demonstrated to be 
robust when considered equivalent to Pearson’s r (Peterson and Brown, 2005) and so were 
entered into the analysis without conversion.     
There are a myriad of awareness measures in the literature and of varying complexity and 
procedure. It is thought that discrepancy measures that compare the report of the person 
with dementia and an informant who knows them well is preferable to self-report or 
informant-only report or clinician interview.  They are also the most widely used method 
(Clare et al., 2005a). Therefore discrepancy based measures were prioritised for data 
extraction. When there was no discrepancy measure other scores were extracted.  Some 
of the measures rated higher awareness as a higher score and others rated higher 
unawareness as a higher score. The depression measures all rated higher scores as more 
depressed. The data extracted was transformed so that in all studies higher scores on the 
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assessment measures meant higher unawareness so that studies could be compared in the 
analysis.   
When possible data relating only to participants with probable Alzheimer’s disease was 
used, in some papers it was not possible to extract data only concerning this population. 
There are some papers included in the analysis containing a sub sample of mix or vascular 
dementia and some with healthy controls.  
Depression is an often investigated correlate of awareness but there are few studies that 
examine their relationship as their primary outcome. Many of the papers examined include 
the associations are secondary data to main aims.  
Awareness is a multi-domain concept covering many areas of a person with AD 
experience including cognitive functioning, daily functioning, and behavioural problems 
(Clare et al., 2005a). When studies reported data from measures examining different types 
of awareness the measure relating to memory functioning or cognitive functioning was 




The analysis was undertaken using the MetaXL software (http://www.epi-
gear.com/index_files/metaxl.html). Meta-analysis of correlations were conducted. A 
random effects model was used due to the differences in measurement, sample type, 
analysis conducted, and the seemingly heterogeneous nature of awareness.  
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No quality criteria were assigned to the papers as it was not considered practical due to 
the number of papers included. The meta-analysis conducted weighs the papers in regards 
to their sample size and highlight areas of heterogeneity and potential bias and so 
additional quality criteria would provide little additional utility.  
Results 
 
 Study Characteristics 
 
The characteristics of the included studies are presented in Table.1. The majority of 
studies were cross-sectional with only two having longitudinal designs; in one of these 
studies the data was taken from baseline data (Aalten et al., 2006) and the other was taken 
from follow-up data (Starkstein et al., 1997). The majority of the studies took place in the 
USA, with five from South America, two from Japan, one from Taiwan and the remainder 




Table 1. Characteristics of included studies 
 
     
Author, year, country Sample  Design Awareness Measure  Depression 
Measure 
Data Extracted Effect Size Entered 
Aalten et al. (2006) 
The Netherlands 
199 (146 AD 32 VD 2 LBD 19 





GRAD  CSDD Odds ratios -0.034 
Bomfim et al. (2007), 
Brazil   
21AD 9 female, age 72.4(8.5) 
MMSE 18.2(5) range 12-24 
Cross-sectional DIS CSDD Pearson’s ra  -0.219 
Chen et al. (2014) 
Taiwan 
55 Ad 32 female age=76.7(7.6) no 
MMSE 




Cines et al. (2015) 
USA 
104 ad age=77.55 (8.03) 
MMSE=24(2.64) 
 Cross-sectional  CRA  GDS (adapted)  Mediation model 
coefficient 
-0.072 
Clare et al. (2010) UK 80AD 43 female 76.5 (7.03) 56-89 
NINCDS-ADRDA criteria 
18>MMSE  
 Cross-sectional  MFD  HADS Pearson’s r -0.072 
Clare, et al. (2012a) 
UK 
101 Early dementia, age=78.4 (7.71 
range 51-91)  
 Cross-sectional MFD HADS Pearson’s r -0.401 
Conde-Sala et al. 
(2013) Spain 
164AD 96 female age=77.6 (7.2) 
MMSE=10-28 mean 17.9 (5.8) 
 Cross-sectional  AQ-D GDS Spearman’s Rho -0.27 
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Table. 1 continued       
Author, year, country Sample  Design Awareness Measure  Depression 
Measure 
Data Extracted Effect Size Entered 
Cummings et al. 
(1995) USA 
33AD, age 71.7 (7.9) MMSE 17.5 
11 female 
 Cross-sectional Modified Memory 
Self-Rating 
Questionnaire 
HDRS  Pearson’s r -0.06 
Degirmenci et al. 
(2013) Turkey 
30AD 15HC 36 female age P 
71.1(8.9) 8severe on MMSE, 24 
mod, 8 mild.  HC 74 (6.8) 
 Cross-sectional BCIS  HAMD Pearson’s r -0.336 
Dourado et al. (2014) 
Brazil 
201AD  age 75.6 (7.3) 58-93 130 
female MMSE 20.3 (3.8)13-27 
 Cross-sectional ASPIDD  CSDD Pearson’s r -0.04 
Feher et al. (1991) 
USA 
38 ad age65.3 50-75MMSE 11-29   Cross-sectional Memory Rating scale 
discrepancy 
HDRS Spearman’s Rho -0.3 
Harwood, et al (2000) 
USA 
91ad 7 female age 71-7(7.9) MMSE 
11(8.6 range 0-28)  
 Cross-sectional NRS  NRS Pearson’s r -0.39 
Horning et al. (2014) 
USA 
107AD 19.91% female age 82.4 
(6.6), MMSE=19.4(4.7) 
 Cross-sectional NRS  NRS Spearman’s Rho -0.22 
Kashiwa et al. (2005), 
Japan 
84AD 62 female, age=75.5(7.8) 53-
89, MMSE=19.5(5) 4-28 
 Cross-sectional QAA GDS Pearson’s r -0.294 
Koltai et al. (2001) 
USA 
14AD age= 72.9(6.7) HC 8 age 
73(7.2) MMSE=22.9(3.6) 
 Cross-sectional EMQ. GDS Pearson’s r -0.591 
Lehrner et al. (2015) 
Austria 
967 total 43 AD 25 female age 74 
(54-84), MMSE=25 (20-29) 
 Cross-sectional FAI-VSRT delayed 
recall converted to z 
scores 
BDI-II Spearman’s Rho -0.140 
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Table.1 continued       
Author, year, country Sample  Design Awareness Measure  Depression 
Measure 
Data Extracted Effect Size Entered 
Mak et al. (2015) 
Singapore 
36 AD age 72.6(8.1) 19 female, 
MMSE=18.2(4.3) 




Migliorelli et al. 
(1995a) Italy 
103AD no other demographic data 
in available version of journal. 




Nakaaki et al. (2008) 
Japan 
42AD 23 females age 72.7(4.2) 
MMSE 19.7(1.4)  
 Cross-sectional SMQ  PDCDAD Correlation and 
ANOVA 
-0.333 
O’Connell et al. (2014) 
Canada 
113 AD, age 75,81 (7.51) RBANS= 
66.16(10.09) (83 completed 
assessments) 
 Cross-sectional Self-Rating of 
Memory Scale and 
RBANS  
CESD Pearson’s r -0.537 
Ott et al (1996) USA 26AD 14 female age 72.5(7.5) 
MMSE 21(3.9), 16n 8 female age 
70.2(5) MMSE 21 (3.9) 
 Cross-sectional MOQ CSDD Pearson’s r -0.15 
Seltzer (1995) USA 36AD 23 female age74.6(6.1) 
MMSE=19.1(4.7) range 10-26 
 Cross-sectional EMQ CSDD Pearson’s r -0.48 
Sevush & Leve (1993) 
USA 
128 AD 69 female age 69.23 (8.49) 
MMSE=17.07 (4.62)  





Pearson’s r -0.338 
Smith et al. (2000) 
USA 
23AD 13 female age=75.3 
MMSE=17.8 (4.4) range 10-26,  
 Cross-sectional Assessment of 
Impaired Insight 
GDS Pearson’s r -0.26 
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Table.1 continued       
Author, year, country Sample  Design Awareness Measure  Depression 
Measure 
Data Extracted Effect Size Entered 
Snow et al. (2005) 
USA  
66 AD 55 control 27% female age 
74.36(8,21)   




Starkstein et al. (1996) 
Argentina  
170ad 56 female 114 age 70.5(5.4) 
MMSE 18.8(6.6) 




Starkstein et al. (1997) 
Argentina 
Dysphoria subgroup n=21 18 
female MMSE=21 (6.4) 
 Longitudinal AQ-D HDRS, SCID Pearson’s r -0.20 
Starkstein et al. (2006) 
Argentina 
750: Severe AD (n=49) 35 female 
age 75.3(8.3) MMSE=8.1(4.1), 
moderate AD(n=169) 107 female 
age 72.9(7.2) MMSE=16.7(4.6), 
mild AD (n=313) 198 female age 
72.6(7) MMSE 22.3(4.1), very mild 
AD (219) 129 female age 68.4 (8.4) 
HC(n=32) 25 female age 68.2 (7.5) 
MMSE=29(1.1)  




Verhey et al. (1993) 
The Netherlands 
103AD, 43 VaD, 24 other 94 
females age 71.2(8.6) 
MMSE18.1(6.1) 2-29 
 Cross-sectional GRAD  DSM-IIIR Spearman’s Rho -0.03 
(Verhülsdonk et al., 
2013) Germany 
47AD age 76.55(7.06) 64-91 
MMSE 19.66(5.88) 8-28 








Table 1. continued       
Author, year, country Sample  Design Awareness Measure  Depression 
Measure 
Data Extracted Effect Size Entered 
(Vogel et al. (2010) 
Denmark 
321 AD  176 female age 76.2(7.2) 
54-92 MMSE=24.4(2.59) 
 Cross-sectional ARS CSDD Spearman’s Rho -0.07 
Zanetti et al. (1999) 
Italy 
69 (37ad 32) VaD female 52 age 
76.7(7.8) MMSE=17(6.4)  
 Cross-sectional GRAD, CIR GDS, NPI Pearson’s r -0.15 
 
Abbreviations: AD- Alzheimer’s disease, HC- Healthy Controls, ad Vascular dementia  
Depression scales: CSDD- Cornell Scale Depression in Dementia, GDS-Geriatric Depression Scale, HADS- Hosptial Anxiety and Depression Scale, 
HDRS- Hamilton Depression Rating Scale, BDI-II- Beck Depression Inventory 2, CESD- Centre for Epidemiologic Studies of Depression, DSM-IIIr 
Diagnostic and statistical Manual III-revised, NPI- Neuropsychiatric Inventory, NOSGER- Nurses Observation Scale for geriatric patients, SCID- 
Structural Clinical Interview DSM 
Awareness scales: BCIS-Beck cognitive insight scale, GRAD- Guidelines for the Rating of Awareness Deficits: semi structured interview. NRS- 
Neurobehavioural rating scale score, ASPIDD- Assessment scale of psychosocial impact of diagnosis of dementia, ARS Anosognosia Rating scale, 
ASPIDD: Assessment scale of psychosocial impact of diagnosis of dementia. CIR: Clinician Insight Rating scale, MOQ-Memory observation 
questionnaire, RBANS repeatable battery of assessment neuropsychological status, SMQ- Short memory questionnaire discrepancy score, AQ-D 
Anosognosia Questionnaire   Dementia, DDS- Dementia Deficits Scale.  MFD Memory Functioning Discrepancy from MARS scale. FAI- Forgetfulness 
Assessment Inventory, VSRT- Verbal Selective Reminding Test, QAA- Quantitative assessment of Anosognosia, PDCDAD-The Provisional Diagnostic 
Criteria for Depression in Alzheimer’s Disease. 
a  Analysis conducted by Author from raw data presented in paper. 
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Association between Awareness and Depression  
 
The correlation between awareness and depression is presented as a forest plot in Figure.2. 
The meta-analysis suggests that there was a small negative association between awareness 
and depression of -0.28 (CI=-0.36- -0.19, N=3468, Q=183.31, p<0.001, I2=84%). There 
was a great deal of heterogeneity in the model.  The Cines et al.(2015) study stands out as 
an obvious outlier reporting a much larger effect size than the other studies. When the 
study was removed from the analysis the heterogeneity reduced considerably but was still 
significant suggesting multiple effects (Q=67.99, p<0.001, I2=57%) in the sample and the 
association reduced to -0.23 (CI -0.28- -0.17).  In order to explain the heterogeneity found 
in the meta-analysis sensitivity analysis was conducted. Cines et al. (2015) was not 
included in any further analysis.  
It was not possible to conduct systematic subgroup analysis due to inconsistent reporting 
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Figure 2. Forest plots for analyses of awareness and depression 
 
Figure 3. Forest plots for analyses of awareness and depression 
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Subgroup analysis by participant subgroup included 
 
In order to examine whether the impact of studies that included participants who did not have AD 
in their sample studies were split into sub groups based on their participants. The analysis is 
included in Figure 3. The mixed dementia participant subgroup (with some participants with 
Vascular dementia and Lewy Body dementia) estimated that the association between 
awareness and depression was -0.-0.05 (CI-0.15- -0.05, N= 414 (107 VD, 19 LBD) 
Q=0.78, p=0.68, I2=0%) with no heterogeneity. The subgroup with AD and Healthy 
controls presented with no heterogeneity suggested an association -0.26 (CI-0.38-0.12, 
N=207, Q=4.83, p=0.67, I2=0%). The subgroup with only AD presented with moderate 
heterogeneity and suggested an association -0.25 (CI-0.31-0.19, N=2847, Q=54.83, 
p<0.001, I2=58%). The AD only subgroup had the same level of association as when all 
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Figure 4 Forest plot for Participant population subgroup analyses of awareness and depression 
 
Figure 5 Forest plot for Dysphoria subgroup analyses of awareness and depressionFigure 6 Forest plot for 
Participant population subgroup analyses of awareness and depression 
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Dysphoria subgroup analysis 
 
It has been found in some studies that mild depression and dysphoria have a different 
relationship with awareness compared to major depression (Migliorelli, 1995a; Starkstein 
et al., 1997). A subgroup analysis of the meta-analysis was conducted to investigate this 
effect. The studies where it could be determined that their sample examined a dysphoria 
sample or studies where major depression was part of their exclusion criteria were 
analysed separately in a subgroup. Six studies contained data that met this criteria 
although for two of the studies the dysphoria data was not the data that was extracted 
(Migliorelli et al., 1995a; Starkstein et al., 1997) and so that data was extracted for a 
separate analysis. This analysis presented with moderate heterogeneity, suggesting a 
correlation of -0.35 (CI:-0.51- -0.17, N=224, Q=8.48, P=0.13, I2=53%). The 
heterogeneity was largely attributable to a single study (Cummings et al., 1995). Once the 
study was removed the meta-analysis indicated an association of -0.42 (CI-0.55 - -0.42, 
N=191, Q=1.90, p=0.75, I2= 0%) (Figure.4) with non-significant heterogeneity and an 
increase in association. This result would seem consistent with the literature that there is 
an association between dysphoria and mild depression opposed to depression as a whole.  
A mixed depression meta-analysis was conducted (Figure.5) with the dysphoria studies 
removed (including the whole sample data of (Migliorelli et al.,  1995a; Starkstein et al., 
1997) and the analysis demonstrated an association of -0.22 (CI -0.27- -0.16, N=3332, 
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Figure 7 Forest plot for Dysphoria subgroup analyses of awareness and depression  
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Subgroup analysis by Awareness measure 
 
In order to explain the heterogeneity of the analysis further the studies were split into 
subgroups based on the awareness measure used. The analysis is presented in Figure.5.  
When three or more studies used the same measure then those studies were grouped 
together. When a measure was only used by one or two studies it was put into the subgroup 
for the type of awareness measure it belonged to; patient/informant (P/I) discrepancy, 
clinical interview, predicted performance discrepancy, or self-report. The studies which 
excluded major depression were not included in this analysis.  
The clinician rating subgroup estimated that the association between awareness and 
depression was -0.32 (CI-0.41- -0.21, N= 326 Q=1.11, p=0.40, I2=0%) with minimal 
heterogeneity. The GRAD (Verhay et al. 1993), a four question clinician interview scale, 
similarly presented with no heterogeneity but the three was a suggestion of no association 
-0.05 (CI-0.15-0.05, N=314, Q=0.68, p=0.71, I2=0%). 
The P/I discrepancy subgroup estimated the association was -0.18 (CI-0.28- -0.07, N=843, 
p=0.06, I2=51%) with substantial heterogeneity. The AQ-D (discrepancy) (Migliorelli et 
al., 1995a) presented with an association of -0.22 (CI -0.27- -0.17 N=1391, Q=3.48, 
p=0.75, I2=0) and no apparent heterogeneity.  
The performance discrepancy measures suggested an association of -0.37 (CI-0.68- 0.06, 
N=126, Q=5.62, p=0.02, I2=82%) with significant heterogeneity. The self-report 
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subgroup suggested an association of -0.44 with some non-significant heterogeneity (CI-
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  -0.39  ( -0.55, -0.20)      4.1
  -0.37  ( -0.68,  0.06)      6.5
  -0.34  ( -0.48, -0.17)      4.8
  -0.34  ( -0.57, -0.05)      2.7
  -0.33  ( -0.58, -0.03)      2.5
  -0.32  ( -0.41, -0.21)     13.4
  -0.30  ( -0.57,  0.02)      2.4
  -0.29  ( -0.48, -0.08)      3.9
  -0.28  ( -0.45, -0.09)      4.4
  -0.27  ( -0.41, -0.12)      5.3
  -0.26  ( -0.42, -0.09)      4.7
  -0.22  ( -0.29, -0.15)      7.3
  -0.22  ( -0.27, -0.17)     32.0
  -0.22  ( -0.39, -0.03)      4.5
  -0.22  ( -0.28, -0.16)    100.0
  -0.18  ( -0.28, -0.07)     29.5
  -0.17  ( -0.31, -0.02)      5.4
  -0.15  ( -0.37,  0.09)      3.5
  -0.15  ( -0.44,  0.17)      2.5
  -0.14  ( -0.42,  0.17)      2.6
  -0.10  ( -0.41,  0.24)      2.3
  -0.07  ( -0.29,  0.15)      3.8
  -0.07  ( -0.18,  0.04)      6.4
  -0.05  ( -0.15,  0.05)     14.3
  -0.04  ( -0.18,  0.10)      5.7
  -0.04  ( -0.32,  0.25)      2.8
  -0.03  ( -0.17,  0.11)      5.6




Figure 10 Forest plot for awareness measure subgroup analyses of awareness and depression   
 
 







The results of the meta-analysis suggested that there is small association between 
awareness and depression in the literature. With those who are more aware, they were 
more likely to report higher levels of depression. There was a large amount of 
heterogeneity suggesting that there were multiples effects being measured within the 
sample of studies. The heterogeneity was reduced when a clear outlier was removed 
(Cines et al., 2015) but was still significant which further suggested that multiple effects 
were present.  The studies that had non-AD participants included did not affect the 
strength of the association or the level of heterogeneity present.  
The Cines et al. (2015) study reported a much greater effect size than the other studies. It 
was distinct from the other studies in multiple ways; it used an unstandardised version of 
the GDS so the validity of measure is not known. The authors argue that this ensured the 
association was not driven by redundancy between the measures. The data extracted was 
a standardised coefficient from mediation analysis between awareness and quality of life 
with depression as a mediator which would mean that any shared variance would be 
controlled for. As this was the only study to examine this it is not possible to determine 
whether this study is different because it is an anomaly or that the nature of relationship 
between the two variables is different when quality of life and the awareness in the GDS 
are controlled for. Preacher & Kelley (2011) argue that using a standardised coefficient 
from a mediation analysis as an effect size measure is unsatisfactory as it does not convey 
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the full meaning of an indirect effect so it may be that the data extracted for the analysis 
may inaccurately represent the findings of the study further. These finding would indicate 
that this study was different to the other studies included, both methodologically and 
conceptually and therefore it was justifiable to remove it from the analysis.  
 
Depression/ Dysphoria subgroup analysis 
 
It has been argued that mild depression or dysphoria and major depression had different 
relationships with awareness, with increases in subclinical levels of depression being 
associated with  increased awareness and major depression not being associated 
(Migliorelli et al., 1995b; Starkstein et al., 1997; Troisi et al., 1996). The subgroup 
analysis conducted in this meta-analysis supports the assertion that there are different 
relationships with awareness for mild and major depression. The dysphoria subgroup was 
found to demonstrate a much stronger association than the other studies and had zero 
heterogeneity suggesting the studies were examining the same effect. This subgroup did 
not account for all of the studies that reported a large association however, by examining 
the means and standard deviations of some of these studies it could be interpreted that 
they had a mild depression sample (Cines et al., 2015; Koltai et al., 2001; O’Connell et 
al., 2014).  However, the studies in the mixed depression subgroup did not differentiate 
between levels of depression and so will likely have a range of mild, moderate and major 
depression within and between studies. This may account for some of the heterogeneity 
in effects as only studies included in the mild depression sub group for the analysis were 
studies where it was clear from their methodology that they had excluded major 
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depression. Nakaaki et al. (2008) argued that moderate, clinical depression has a different 
relationship with awareness, with decreased mood leading to either more accurate or 
underestimation of memory functioning. This was the only study to put forward this 
perspective but it cannot be ruled that this effect is contributing to the heterogeneity in the 
analysis.       
The Cummings et al. (1995) study accounted for all the heterogeneity in the dysphoria 
subgroup. The exclusion criteria for the sample differed greatly from the rest of the sample 
studies in regards to depression, excluding anyone who was currently taking anti-
depressants or had experienced depression in the past. This would indicate, therefore, that 
the sample they investigated is likely to different from the other studies in the subgroup.  
Troisi et al. (1996) argued in their study that psychological but not somatic symptoms of 
depression are associated with awareness. Unfortunately, it is not possible to examine this 
notion within this review as the majority of the depression measures used in the included 
studies examine a range of depression symptom types.   
 
Awareness measures analysis  
 
The method used to assess awareness was found to have an impact on the association 
between awareness and depression with some measures finding a small association and 
others not. The findings that different measures found different sized effects reinforces 
the view of Clare et al. (2005) and Snow et al. (2004) that a multi-dimensional approach 
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to measuring awareness is needed in order to account for the differing effects found with 
different measure types. The effects found in each subgroup are discussed below.  
 
Clinician rating subgroups 
 
From the  studies that used the GRAD (Verhey et al., 1993) there was no association while 
those using other mixed clinician rating methods found an effect more in line with the 
whole sample analysis. This would seem to suggest that the lack of the association found 
in the studies in the subgroup was to do with the nature of the measure.  These three papers 
are also the three papers included in the analysis that included participants with vascular 
dementia which may also provide some explanation for the lack of association found. The 
GRAD is a four question structured interview examining memory functioning, full 
awareness scores are given when the individual with dementia reports complaints of their 
memory functioning to the question “tell me about the problems you are here for?” and 
their responses are consistent with caregiver reports. It seems likely that people with 
dementia could fail to respond as desired to that question for reasons other than awareness 
of memory function. Therefore, this measure would be assessing individuals on more than 
just that object of awareness. The fact that all three studies reported a similar level of 
association would seem to demonstrate that the measure is consistent from the data 
available but the aspect of awareness it is examining appears to be different from other 
measures included in the analysis.  
The mixed clinician rating subgroup contained a variety of measures but there was a lack 
of heterogeneity in effects found and a slightly higher effect was reported for this group. 
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This would suggest that despite the different measures used, the same effect was being 
measured. This would support the notion that clinicians have an expectation of what 
“normal” awareness is and they consider similar factors important (Clare et al., 2005a) 
and those factors are associated with depression.     
 
Patient/Informant discrepancy measures subgroups  
 
The AQ-D demonstrated no heterogeneity and a small association. The Snow et al. (2005) 
data included in the AQ-D analysis was comparing the patient/clinician discrepancy as 
the data for the patient/caregiver model was regression model was not included. Despite 
this difference the analysis appeared to have little affected as the results extracted are in 
line with other studies in the group. This demonstrates that the AQ-D consistently 
examined the same effect. The AQ-D is a general measure of awareness and examines 
two different objects of awareness, cognitive functioning and behavioural changes.  
The mixed patient/informant group demonstrated moderate heterogeneity and a small 
association. The moderate heterogeneity may be accounted for by the range of different 
measures used examining different aspects of awareness. Many of the measures report 
that the object of awareness examined is cognitive functioning/difficulties or memory 
functioning/difficulties. The heterogeneity found in this subgroup would seem to suggest 
that these measures are not examining the same effect even though their reported object 
of functioning appears to be similar. This assessment method assumes that informants are 
able to provide objective and reliable ratings of patient awareness, the evidence as to 
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whether this is the case is unclear (Clare et al., 2002; Snow et al., 2004; Starkstein et al., 
2006). Therefore, the notion that heterogeneity in the findings of the mixed subgroup 
studies could also be explained by the potentially inconsistent and unreliable informant 
reports cannot be ruled out.  
 
Performance discrepancy subgroup 
 
There were only two studies using predicted performance measures in the analysis and so 
it is difficult to draw conclusions about the nature of this subgroup. The 
neuropsychological measures the studies used examined different constructs with 
(Lehrner et al., 2015) examining delayed recall and (O’Connell et al., 2014) examining a 
performance of a number of neuropsychological tasks including memory, language, 
attention and visuospatial abilities, so it is unsurprising that they found such different 
results. Theoretically it would be expected that the performance discrepancy group would 
differ from the other subgroups as they examine a different level of awareness i.e. 
performance monitoring rather than evaluative judgement of their memory functioning.   
 
Self-report subgroup  
 
The self-report group suggested a small association consistent with the larger analysis and 
demonstrated some significant heterogeneity. Similarly, to the performance discrepancy 
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group it only contained two studies subgroup using different measures and so little 
conclusion can be drawn about the nature of this subgroup. 
 
Limitations of the review 
 
There were some methodological limitations to the data extraction which may have had 
an impact upon the findings of this analysis. As most of the data extracted was secondary 
data, the data needed for this review was not always a priority for the researchers to report. 
Some of studies screened did not report non-significant findings so could not be used in 
the analysis. The effect size found in the meta-analysis was small so it is not clear the 
effect these studies would have had on the overall correlation coefficient. Some of the 
studies had small sample sizes and may have just been underpowered so they may have 
contributed to the overall effect or they might have reduced it. Some of the included 
studies also did not report non-significant findings which may have been more appropriate 
for data extraction. Rather than not include studies it was decided to convert other 
statistics that were reported even if they were not the preferable measure, for example a 
correlation with caregiver rated depression and awareness (Starkstein et al., 2006). This 
may have introduced bias into the analysis as these statistics tended to be reported because 
they were significant. It may have also introduced more heterogeneity.  
It may be that there are relevant studies that have not been included in the analysis. There 
were some studies that were omitted that the author was unable to obtain that seemed to 
be appropriate from reviewing the abstract.  No attempt was made to contact authors and 
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obtain unpublished studies or raw data to include in the analysis as these papers would 
not have been subjected to peer review. It may be then that the analysis is open to the 
publication bias of studies with significant findings being more likely to be published. As 
the data being extracted was predominantly secondary data the analysis may be less 
effected by publication bias.  
 
Clinical implications  
 
This meta-analysis would seem to suggest that there are distinct relationships between 
mild and major depression and awareness. This would support the notion that mild 
depression in awareness may be a psychological response to adapting to changes in AD 
(Migliorelli et al., 1995b). Therefore, it would be important for services to assess 
awareness using a patient/informant discrepancy measure when assessing depression. A 
patient/informant measure should be used as this is the type of awareness measure used 
in the studies which found the effect. It would also be important to choose the measure of 
awareness depending on what aspect of awareness it was considered important to 
investigate such as awareness of memory functioning. Being able to identify those with 
awareness more readily can also be helpful in identifying how best to support those 
dealing with dementia as those who have awareness, would be likely to benefit from extra 
support and counselling whilst, those with dementia who lack awareness, it would be more 






This analysis illustrates that only mild depressive symptoms are associated with 
awareness. Further research is needed to determine whether the depressive symptoms 
associated with awareness are psychological responses and the factors that influence the 
responses people tend to make. It also means that it would be important to examine further 
relationship that other psychological responses such as anxiety and distress have with 
different types of awareness. There is already some evidence to suggest that these factors 
are associated (Clare et al., 2011).  It is also important that future research is conducted 




The meta-analysis conducted suggests that there is small effect between depression and 
awareness. There appear to be multiple effects present. Mild depression appears to have 
a separate moderate effect with awareness. It would seem that the different methods of 
assessing awareness are likely to be measuring different aspects of awareness and that 
these aspects have differing relationships with depression. These findings demonstrate 
that neither depression nor awareness are unitary concepts in AD and therefore highlights 
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Background: Unawareness of memory functioning is a key symptom of Alzheimer’s 
disease and dementia that has been demonstrated to be related to Quality of Life (QoL) 
and other important factors for the person with dementia (PwD) and their family 
caregivers. Understanding more about how awareness relates to these factors will help 
inform how PwD and their caregivers are best supported.    
Objective: The present study examined the contribution awareness and caregiver related 
factors provide to explaining PwDs’ QoL. Both PwD self-ratings and caregiver ratings of 
the PwD they care for of QoL were examined as they have been shown to be affected by 
different factors.  
Method: 27 PwD and their caregivers were recruited. In order assess the research aims 
the PwD completed measures of: Quality of life (Quality Of Life-Alzheimer’s Disease 
scale), awareness of memory functioning, cognitive functioning, depression and anxiety. 
The caregiver completed measures of: PwD Quality of life, memory functioning proxy, 
self-ratings of depression and anxiety, activities of daily living, Neuropsychiatric 
symptoms, caregiver burden, and relationship quality with PwD. 
 Results: Awareness was not found to predict PwD or caregiver rated PwD QoL. No 
caregiver variables predicted PwD QoL. Depression and neuropsychiatric symptoms 
predicted PwD QoL. Caregiver rated QoL was predicted by activities of daily living and 
caregiver rated quality of caregiving relationship. 
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Conclusions: Awareness was not found to be related to PwD or caregiver PwD QoL. The 
quality of caregiving relationship is important to QoL in a dementia context. PwD and 




Quality of life in Alzheimer's disease and Dementia 
 
Alzheimer's disease (AD) is a chronic, progressive illness which often leads to significant 
emotional and physical distress as well as an array of complex behaviours that challenge. 
Many people with dementia (PwD) (of which AD is one of the most common forms of) 
have to move into care homes when their needs become too great as the illness progresses. 
Those who remain at home are often primarily reliant upon informal caregivers most 
frequently spouses and adult children. Informal caregiving is the act and experience of 
providing help and assistance to relatives or friends who are unable to provide for 
themselves (Hunt, 2003). It is estimated that for every thousand people with dementia 
there are 850 people acting as primary caregivers (Knapp et al., 2007; NICE, 2006).  These 
factors suggest that research and interventions should focus on further understanding and 
measuring Quality of Life (QoL) or Health related QoL (HRQL) in Alzheimer’s disease 
and dementia as well as cognition and behaviour (Banerjee et al., 2009). There is no clear 
definition of QoL in dementia but there is agreement about what many of the key 
components are; ability to experience positive emotions, enjoyment and feelings of 
belonging, and absence of depressed mood and anxiety are generally agreed to be 
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important factors in QoL in dementia. There is disagreement, however, about the breadth 
of the definition as, if it is too broad, it starts to lose utility and become reflective of other 
symptoms of the disease such as functional impairment (Ready et al., 2004).  
 
The most common ways of measuring QoL is to use self-report assessments (QoLp) or 
informant/ caregiver rated assessments (QoLc)(Selai et al., 2001). Measuring self-rated 
QoL can be difficult due to poor recall, time perception, insight and communication in 
many PwD. The literature seems to suggest that self-report QoL ratings of PwD can have 
good validity and reliability in the majority of cases in mild to moderate dementia 
(Banerjee et al., 2009).  Karlawish et al. (2001) demonstrated caregivers of people with 
mild to moderate dementia could provide ratings of patient QoL with good test-retest 
reliability. caregiver proxy and PwD ratings of QoL have been found to be strongly 
associated (Thomas et al., 2006) although caregivers are have been found to rate QoL 
lower than PwD and that disagreement was shown to be associated with lack of awareness 
(Vogel et al., 2006). 
 
Nature of Awareness in Dementia 
 
One variable that has received much focus in recent studies in terms of what determines 
QoL is “awareness of symptoms” or “insight”. The terms Anosognosia, unawareness, and 
denial of illness have also been used to describe this phenomenon (Clare, 2004). There is 
no agreed upon definition of awareness (as it will be referred to in this study) but it can 
be defined as the “reasonable or realistic perception or appraisal of a given aspect of one’s 
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situation, functioning or performance, or the resulting implications, which may be 
expressed implicitly or explicitly.”(Clare et al., 2012b). In AD, when awareness is 
examined it is most frequently referring to the symptom of lack of awareness of memory/ 
cognitive functioning, for the purposes of this study when awareness is discussed it will 
be referring to awareness of memory functioning unless otherwise stated.  A four factor 
biopsychosocial theoretical model of awareness has been proposed which identifies 
awareness phenomena operating at different levels: sensory registration (basic awareness 
of environment), performance monitoring (ability to monitor performance on a certain 
task), evaluative judgment (evaluation of ability in a specific domain such as memory), 
and meta-representation (reflection on changes of a person’s situation and their 
impact)(Clare et al., 2011b). This is a recent new model and much of the literature does 
not conceptualise awareness using this model or even differentiate between the levels of 
awareness. Most measures used in studies investigating awareness examine the evaluative 
judgement level of the model although there are some studies examining performance 
monitoring awareness (Lehrner et al., 2015; Woods et al., 2014). Awareness is a complex, 
multifactorial construct requiring precise in-depth analysis to understand each of the 
proposed levels and explain the contribution made by organic and psychosocial factors in 
influencing those levels. Due to its complex nature it is important to acknowledge that 
different measures examining awareness may be evaluating different constructs and so it 
is important to be precise in how assessments of awareness are described (Clare et al., 
2005a). In order to be consistent with the majority of the literature this study is concerned 




Influence of Awareness on Quality of Life 
 
Banerjee et al. (2009) reported in a systematic review of studies of determinants of QoL 
up to 2007 that awareness (defined simply and broadly as “insight”) was not found to be 
associated with QoL in early dementia and that there was a lack of data investigating 
moderate to severe dementia. Since the review was published there have been a number 
of studies suggesting that increased awareness is related to lower QoL. It has been argued 
that unawareness may be protective for PwD from comprehending the changes they are 
experiencing and is often reported by caregivers that they feel that this is the case (Hurt 
et al., 2010).  Hurt et al. (2010) demonstrated that awareness to be predictive of QoL in 
PwD in regression analyses for both mild and moderate dementia with impaired awareness 
being associated with better QoL. However, awareness in this study was measured by a 
single dichotomous item rather than a validated measure of awareness. Trigg et al. (2011) 
found a similar association using the Memory Functioning Scale from the Memory 
Awareness Rating Scale (MARS), a validated and reliable measure of awareness and 
found that awareness was the strongest predictor of QoL ratings (as rated by Bath 
Assessment of Subjective Quality of Life in Dementia (BASQID)) with activity 
performance and enjoyment of activities also being significant predictors in a sample of 
people with mild Alzheimer's disease.  Conde-Sala et al. (2014) also found awareness to 
be the strongest predictor of self-rated QoL in PwD (measured by QOL-AD), using the 
Anosognosia questionnaire- Dementia (Migliorelli et al., 1995a) which examines 
cognitive awareness and behavioural changes. Awareness was also found to be a 
significant predictor in caregiver rated QoL of PwD although functional abilities was the 
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strongest predictor. Awareness was also the strongest predictor of the discrepancies 
between the ratings of caregivers and PwD. Woods et al. (2014) demonstrated that 
awareness (memory functioning discrepancy scores and functional activities discrepancy 
scores) was associated with QoLp (QOL-AD) in bivariate correlations but when they were 
entered into their regression model with other variables they were no longer significant 
predictors and they concluded that awareness plays little, if any, role in predicting QoLp.  
 
Depression and Awareness in relation to Quality of life 
 
The literature on depression and awareness suggested that higher awareness is associated 
with more depression. However, there are a number of studies that have failed to find an 
association between depression and awareness (Aalten et al., 2005a; Mograbi and Morris, 
2014; Starkstein, 2014). There are also studies that found that the association was only 
between mild depression and awareness but not major depression (Migliorelli et al., 
1995b; Starkstein et al., 1997); in particular associated with psychological symptoms of 
depression (mood, ideation, anxiety) rather somatic symptoms (fatigue, slowness). It has 
been suggested that mild depression in awareness may indicate an emotional reaction to 
awareness of functional deficits and that it may be protective for them, a perspective often 
reported by caregivers (Hurt et al., 2010; Migliorelli et al., 1995b).  
 
Depression has consistently been established as a strong predictor of low QoL when rated 
by PwD (Banerjee et al., 2009; Conde-Sala et al., 2014; Hurt et al., 2010; Naglie et al., 
2011a). This makes intuitive sense as depression and mood is often considered a key 
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component of QoL. Woods et al. (2014) demonstrated through mediation analysis that the 
relationship between awareness and QoLp was mediated by depression and self-concept. 
Cines et al. (2015) also reported that awareness and QoL had medium to large indirect 
association via depressed mood. A modified geriatric depression scale was used in the 
study with awareness related items removed so there was no overlap between the 
measures. These studies argue that the association between awareness and QOLp is 
dependent on depression. This brings into question the findings of Trigg et al. (2011) in 
relation to awareness of memory functioning and QoLp as a measure of depression was 
not included in their model and so any variance that could potentially explained by 
depression was not accounted for. 
 
Person with Dementia self-ratings of Quality of Life 
 
As well as examining depression and awareness in relation to QoLp, there have been a 
number of studies examining factors that predict PwD ratings of their own QoL 
particularly in recent years. There is a large variation in the variables that have been 
included in each study’s regression models which makes it difficult to compare the studies 
and draw conclusions about the respective contributions each variable provides to 
explaining QoLp.  
The most comprehensive study examining  predictors of QoLp in terms of number of 
variables examined was Woods et al. (2014) in their study of early stage dementia in 
Wales. They conducted six initial models examining different domains (person with 
dementia domains: background, psychosocial, and neuropsychological, Caregiver ratings 
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of PwD, caregiver self-ratings and background variables, and Awareness) and then 
derived their final model from the significant predictors in those domains. Their final 
model explained 57% of the variance in their sample, a larger proportion than other 
models have reported (Naglie et al., 2011a; Orgeta et al., 2015) and comparable with 
Conde-Sala et al. (2014). The model included depression, severity of irritability (an item 
from the Neuropsychiatric inventory), self-concept (a person’s self-knowledge), PwD 
rated quality of relationship, and male gender as significant predictors. Other large studies 
have demonstrated that neuropsychiatric symptoms (behaviours that challenge) 
significantly negative predict QoLp (Conde-Sala et al., 2014), although Naglie et al. 
(2011a) found them to only explain a small amount of variance in their large Canadian 
multisite study. These studies examined total scores of the measure rather than examining 
the items individually. Positive ratings of the relationship to the caregiver has also been 
shown to be a predictor of QoLp in other studies, both in a cross-sectional study (Menne 
et al., 2009) and in a longitudinal study although caregiver rated quality of relationship 
was not found to predictive (Clare et al., 2014). PwD rated Quality of caregiving 
relationship has not investigated as frequently as other variables but its positive 
relationship with QoLp is a consistent finding.  The caregiver participants in the studies 
were mostly spousal caregivers with adult children making up the majority of the 
remaining participants.  
Banerjee et al. (2009) stated in their review that there was little evidence that activity 
limitation had an impact upon QoLp. Since that review was published a number of studies 
have supported that position (Gary Naglie et al., 2011; Woods et al., 2014) and some 
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studies that have found an increase in activities of daily living leads increased QoLp 
(Conde-Sala et al., 2014; Trigg et al., 2011). 
The evidence in the literature would seem to suggest that caregiver burden/ caregiver 
stress does not predict QoLp. Some of the large studies of have found that it is not 
predictive of QoLp (Conde-Sala et al., 2014; Naglie et al., 2011a). Orgeta et al. (2015) 
found caregiver burden to be the only significant predictor of QoLp in their model of 
caregiver factors and explained a very small amount of variance (3%). It was only entered 
with caregiver wellbeing and self-rated health which were not significant predictors and 
it seems unlikely that if it were entered with stronger predictors of QoLp that it would 
remain a significant predictor. Taking these factors into account this makes this finding 
consistent with Woods et al. (2014) who showed that caregiver burden was associated 
with QoLp but was not a significant predictor in their caregiver self-rating model of QoLp.   
 
Caregiver ratings of Quality of Life for person with dementia they care for 
Caregiver ratings of PwD QoL have not received the same amount of attention as PwD 
ratings but it is important to examine factors determining their ratings as they are often 
considered the most accurate account of how the PwD they care for is feeling. It seems 
apparent in the literature that the way that caregivers appraise PwD QoL is different to the 
PwD themselves, variables that do not seem to be predictors of QoLp have been 
demonstrated to be predictors of QoLc. Unlike in PwD self-ratings of QoL Activity 
limitation/ activities of daily living has been consistently shown to be a strong predictor 
across studies of PwD in community settings with increases in ability to take part in daily 
activities leading to increases in QoL (Conde-Sala et al., 2014; G Naglie et al., 2011b; 
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Orgeta et al., 2015; Snow et al., 2005a). It has been shown to be an important predictor of 
QoLc in care home residents as well (Sloane et al.2005).  There is somewhat strong 
evidence that Neuropsychiatric symptoms are negatively associated with QoL ratings by 
caregivers (Banerjee et al., 2006; Hoe et al., 2007; Karlawish et al., 2001) although some 
studies have not found the relationship (Naglie et al., 2011b). Similarly caregiver burden 
has been demonstrated to be predictive  of PwD QoL by some large studies models (Josep 
L Conde-Sala et al., 2014; Orgeta et al., 2015)  but not in others (G Naglie et al., 2011).   
 
 
PwD/Caregiver ratings discrepancies 
 
It is clear that from previous research PwD appraise ratings of their own QoL differently 
from their caregivers. Fernanda et al. (2013) showed that awareness of disease and 
depressive symptoms, played an important role in the differences between the self-
reported QoL ratings and the caregivers’ QoL ratings.  Conde-Sala et al. (2014) furthered 
this finding also showing that awareness and depression were predicative of the 
discrepancies in ratings but also showing that severity of dementia and caregiver gender 
were predictive. Gitlin et al. (2014) suggested that the disparity in ratings of PwD and 
caregivers may be due to caregivers viewing PwD as suffering while higher ratings may 
be due to caregivers viewing PwD as having greater capacity than they actually have. In 
a study examining caregiver burden and patient QoL rated by patients and caregivers, half 
of the caregivers of PwD thought their ratings of patient QoL would be different to how 
the patient would rate them. It was suggested that this could be attributed to the caregiver's 
experience of depression and burden leading them to view the situation more negatively 
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(Karlawish et al., 2001).  Both PwD and caregiver perspectives need to considered and it 
may be that caregivers would benefit from interventions that improve their understanding 
of PwD needs, perspectives, and capabilities  to improve quality of life for both groups 
(Gitlin et al., 2014).  
 
Caregiver mental health and wellbeing and quality of life  
 
One area that has received limited investigation is the relationship that caregiver’s own 
wellbeing and QoL has with ratings of PwD QoL. It has been demonstrated that a 
significant proportion of PwD are aware of their caregiver’s anxiety and psychological 
health and while that may mean they are more able to in turn support their caregiver it 
may also mean that they become distressed themselves. Awareness of caregiver’s 
psychological health awareness was found to be independent awareness of memory 
functioning therefore suggesting that those with poor memory functioning awareness may 
have an awareness of their caregiver’s emotional state (Ablitt et al., 2010). This awareness 
combined with the finding that caregivers are more likely to report poor QoL compared 
to aged matched peers in the general population (Argimon et al., 2004) would seem to 
suggest that caregiver wellbeing is likely to have an effect upon PwD QoL. There is some 
evidence to suggest this is the case. Increases in caregiver mental health has been shown 
to be associated with increases in QoLp (Argimon et al., 2004). Caregiver QoL has been 
found to significantly predict caregiver rated QoL in a model along with NPI and activity 
limitation. It was also found that caregiver depression related to patient depression and 
partially condition PwD QoL (Thomas et al., 2006), This was with a moderate to severe 
74 
 
dementia sample whereas much of the research literature has examined mild dementia. 
Caregiver depression has been demonstrated to significantly predict caregiver rated QoL 
in a model along with patient depression and activity limitation (Snow et al., 2005a). 
However, caregiver mental health measured by GHQ was found to not be a significant 
predictor of QoLp, with NPI and age being the only significant predictors of QoLp in that 
model (Banerjee et al., 2006).  
 
 
Research questions and Hypotheses 
 
The present study aims to investigate the factors influencing PwD QoL as measured by 
the QOL-AD with particular focus on awareness of memory functioning (MF) and 
variables relating to the caregiver and caregiving relationship.  By understanding more 
about the nature of awareness and factors impacting on QoL means that interventions can 
be tailored more to people’s needs. It has been demonstrated that caregivers appraise PwD 
QoL differently to self-report and so it is important to understand both perspectives. 
Particularly as caregiver perceptions of PwD and their QoL are frequently how clinicians 
are informed of PwD wellbeing. It has also been shown that there are multiple levels to 
awareness and so it is important to examine how differing levels relate to PwD QoL, 
namely evaluative judgements of memory functioning and performance monitoring of 
memory functioning.  There is some evidence to suggest that awareness of memory 
functioning is related to PwD QoL but at this time its relationship is unclear. It is important 
to examine variable’s relating to caregivers wellbeing and Quality of Life as it has been 
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shown that caregivers’ distress and their responses to it can have an impact upon the PwD 
(Ablitt et al., 2010). Low caregiver QoL has also been demonstrated to be a predictor for 
admission of PwD to a nursing home (Argimon et al., 2005). PwD rated relationship 
quality has been found to be predictive of QoLp and therefore it would seem that 
caregivers’ perception of relationship quality influence QoLc.   Much of the research 
examining awareness has focussed on early stage dementia and it was planned to include 
more moderately cognitively impaired participants and the adjusted version of the 
Memory Awareness Rating Scale (MARSA).  
Research question 1: Does awareness of memory functioning and factors affecting 
caregivers (caregiver-rated relationship quality, caregiver burden caregiver wellbeing and 
quality of life) significantly predict PwD ratings of their own Quality of life?  
Hypothesis 1: Increases in awareness of memory functioning will significantly predict 
decreases in PwD ratings of their quality of life. Increases in caregiver rated relationship 
quality, caregiver wellbeing and quality of life will significantly predict increases in PwD 
ratings of their quality of life.   
Research question 2: Do awareness of memory functioning and factors affecting 
caregivers significantly predict how caregivers rate quality of life for the PwD they care 
for?  
Hypothesis 2: Increases in awareness of memory functioning will significantly predict 
decreases in caregiver ratings of quality of life for the PwD they care for. Increases in 
caregiver rated relationship quality, caregiver wellbeing and quality of life will 
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significantly predict increases in caregiver ratings of quality of life for the PwD they care 
for.   
Secondary research question: Does awareness predict caregiver quality of life?  
Hypothesis: Decreases in the level of PwD awareness will predict significant decreases in 






The study used a cross-sectional design, using hierarchical multiple regression analyses 
to investigate the relationships between the criterion variable, patient rated quality of life 
and patient and caregiver predictor variables of; patient and caregiver mood, caregiver 
burden, behaviour that challenge, caregiver quality of life, relationship quality and 
awareness (patient/ informant discrepancy ratings and predicted performance).  
This study presents cross-sectional data from initial assessments of a longitudinal study 
examining awareness and quality of life in people with mild to moderate dementia. Ethical 
approval for the study was granted by University of Edinburgh and NHS Lothian Ethics 








The sample comprises 27 people with mild to moderate dementia and their caregivers who 
were selected from patients diagnosed with Alzheimer's disease who are supported by 
caregivers and were involved with the Community Mental Health Team-Older Adults. 
The Dementia Link and Community Psychiatric Nurses’ caseloads were screened to 
identify eligible participants.  People with dementia who were identified as potentially 
eligible were invited to consider participating in the study when they are attended clinics 
or appointments with nurses and then were approached by researchers if agreeable. 
Participants were seen at home and people with dementia were seen separately to their 
caregivers. All gave informed consent. In order to minimise participant burden patients 
were typically seen in two one hour appointments and were supported to complete 
measures. If participants did not feel they were able to complete that length of 
appointment shorter appointments were offered. Researchers regularly checked with 
participants to determine how they were coping with the measures and if there were any 







 Patient participant must have a diagnosis of Alzheimer's disease or mixed 
dementia (Alzheimer's/ Vascular dementia) from their consultant psychiatrist  
 Patient participant must have a Mini Mental State examination (MMSE) (Folstein 
et al., 1975) score above 12 at their last appointment with the Dementia Link 
Nurse. The MMSE is a dementia screening tool routinely used and scores under 
12 are considered to suggest severe dementia.  
 The caregiver participant must spend at least 4 hours per day at least 4 days per 
week with the patient and have some knowledge about the patient’s daytime and 
night time behaviours (as recommended by the Neuropsychiatric Inventory which 
has the most conservative definition of all the measures being proposed).  
 Patient participant aged over 65. 
 Patient participant must be receiving cognitive enhancer medication or eligible to 
receive cognitive enhancer medication. 
 Participants must have sufficient visual and auditory sensory performance to 
complete measures. 
 Participants must be able to speak sufficient English to complete assessments. 
 
Exclusion criteria 
 The presence of dementia of non-Alzheimer's dementia pathology in the patient 
participant, including Parkinson's disease, Frontotemporal dementia.  
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 The presence of clinically significant acquired brain injury, substance misuse or 
other factor contributing to abnormal brain functioning in the patient participant. 
 Clinically significant functional psychiatric symptomology for patient participant. 
 A diagnosis of moderate, severe or profound learning disability for either 
participant. 
 Delirium in patient participant.  





A questionnaire collecting demographic information (Appendix I.) was administered 
examining; the characteristics of the patient and caregiver: Age, gender, patient dementia 
diagnosis, socioeconomic status (profession/previous profession), and other health 
conditions/support needs. The characteristics of relationship: relationship of caregiver to 
patient, living arrangements, and any additional support provided from other sources. 
 
Quality of life- Alzheimer's disease 
Quality of life-AD (QOL-AD) (Logsdon et al., 1999) is a 13-item measure developed to 
rate the quality of life of people with dementia with reports from both the patient and 
caregiver. Higher scores suggest better quality of life. The caregiver scale is administered 
in self-report format while the patient scale is administered in an interview format. The 
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QOL-AD has been found to have good reliability and validity for those scoring over 10 
on the MMSE, demonstrating good concurrent validity with measures of depression and 
everyday functioning (Logsdon et al., 2002). It was the preferred measures in an 
evaluation of outcomes measures in psychosocial interventions in dementia (Moniz-Cook 
et al., 2008).  The patient rated and caregiver rated QOLAD were found to be highly 
reliable in this sample (α=0.862 and α=0.871 respectively). 
 
Memory Awareness Rating Scale Adjusted 
Memory Awareness Rating Scale Adjusted (MARSA) (Hardy et al., 2006) is an updated 
version of the Memory Awareness Rating Scale (MARS) (Clare et al., 2002) developed 
to be more suitable for use with a broader range of participants such as those with 
moderate Alzheimer's disease. The MARSA has two scales and generates two discrepancy 
scores. The first is the patient/informant discrepancy score derived from the participants 
and informants’ responses to the Memory Functioning scale (MFS). The MFS items ask 
participants about their own perceived memory ability in a range of typical everyday 
scenarios and the same items are given to their caregiver. A positive discrepancy suggests 
a participants’ overestimation in their abilities and a negative discrepancy suggests an 
underestimation. The discrepancy is calculated using a corrected discrepancy ((MFS-P – 
MFS-C)/((MFS-P + MFS-C)/2)) so that equal weight is given to both ratings that 
subtracting the caregiver score from the PwD score does not achieve (Clare et al., 2010). 
This scale examines the evaluative judgement level of awareness. In the second scale the 
participant is asked to complete some memory tasks and they are asked how they thought 
they performed. Their objective performance is then compared to their perceived 
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performance and an objective/perceived performance discrepancy score is calculated. In 
the MARSA the tasks from the MARS based on the Rivermead Behavioural Memory Test 
(Wilson., et al, 1985) and Severe Impairment Battery (Panisset et al., 1994). This scale 
examines the performance monitoring level of awareness. The MARSA was found to have 
good internal consistency and good test-retest reliability (Hardy et al., 2006).  The scales 
of the MARSA were all found to be reliable in this sample (MFS-C α=0.868, MFS-P 
α=0.897 MARSA task α=0.795 MARSA task self-rating α=0.714) 
 
Adenbrooke’s Cognitive Examination Revised 
The Adenbrooke's Cognitive Examination Revised (ACE-R) is a well validated and 
reliable screening measure of cognitive impairment and has been found to be useful in 
detecting and differentiating between different forms of dementia (Hsieh et al., 2013). In 
a systematic review of the ACE-R's validity and clinical utility it was found to differentiate 
well between those with and those without cognitive impairment (Crawford et al., 2012). 
The internal consistency of this scale was high in this sample (α=0.830) 
 
WHOQOL- BREF 
The World Health Organisation Quality of life Brief (WHOQOL-BREF) is a 26 item 
question that examines four domains relating to quality of life: physical health, social 
relationships, psychological and environment and an item on overall quality of life and 
general health (WHOQOL group, 1998a). It has been demonstrated to have good 
discriminant and content validity, internal consistency and test-retest reliability 
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(WHOQOL group, 1998a).  The social relationship subscale was not found to be reliable 
in this sample (α=-0.047) and so was not included in any of the analysis. The other 
subscales were found to be reliable (physical health α=0.795, psychological α=0.707, 
environment α=0.721).  
 
Zarit Burden Interview 
 Zarit Burden Interview (ZBI) (Zarit et al., 1980) is a 22 item self-report measure 
administered to the caregiver. It assesses the burden the caregiver feels related to 
functional/behavioural impairments and day to day living with the patient. The ZBI has 
been found to be reliable and have good construct validity, particularly in relationship to 
depressive mood and challenging behaviour (Hebert., et al 2000). The ZBI was found to 
be highly reliable in this sample (α=0.906). 
 
Hospital Anxiety and Depression Scale 
The Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith, 1983) is a 14 
item self-report measure with two sub-scales, one measuring depression and one 
measuring anxiety. It has been shown to have good reliability and validity and to be 
applicable in community settings as a screening tool (Snaith, 2003). Dennis et al., (2007) 
found that the anxiety sub-scale of the HADS while not completely adequate, along with 
BAI, was the most suitable measure to use with older adults.  It also has been demonstrated 
to have a clear two factor structure, good homogeneity and internal consistency (Mykletun 
et al., 2001).  The HADS has been demonstrated to adequately screen depression in those 
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with dementia (Wands et al., 1990). It was also chosen for use in the study as not all 
caregiver participants in the study would be older adults. The patient rated and caregiver 
rated HADS were found to be highly reliable in this sample (patient: Anxiety α=0.785, 
Depression α=0.829 caregiver:  Anxiety α=0.820 Depression α=0.774).  
 
Burns Relationship Satisfaction Scale 
The Burns Relationship Satisfaction Scale (BRSS) (Burns & Sayers, 1988) is a 7 item 
self-report measure that assesses different areas of relationship satisfaction including 
communication and openness, conflict, affection and intimacy and overall satisfaction 
with the relationship. It has been demonstrated to have internal consistency and to 
correlate strongly with other relationship satisfaction measures, Dyadic Adjustment scale 
and Norton's Quality of Marriage Index (Heyman et al., 1994). The BRSS was found to 
be highly reliable in this sample (α=0.964). 
 
Neuropsychiatric Inventory Questionnaire      
The Neuropsychiatric Inventory Questionnaire (NPI-Q) (Kaufer et al., 2000) is based on 
the Neuropsychiatric Inventory (Cummings, 1997). The NPI is a short structured 
interview conducted with a caregiver of a person with dementia. It assesses the severity, 
frequency and distress of 12 types of disturbances common in dementia. The NPI-Q was 
designed as a brief 12 item self-report measure; caregivers are asked if a symptom is 
present, to rate the severity of the symptom and the level of distress it causes them. A total 
score can be derived by multiplying the distress scale by severity of symptoms. The NPI-
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Q  has demonstrated good test-retest reliability and convergent validity with the NPI 
(Kaufer et al., 2000) which has established content validity, concurrent validity, inter-rater 
reliability, and test-retest reliability (Cummings, 1997). The NPI-Q subscales were found 
to be highly reliable in this sample (Severity α=0.835 distress α=0.856).   
 
Disability Assessment for Dementia 
The Disability assessment for Dementia (DAD) (Gélinas et al., 1996) is a 40 item measure 
administered to caregivers examining functional disability in people with dementia. The 
items focus on basic self-care and instrumental activities of daily living. It has been 
demonstrated to have strong internal consistency and good interrater and test-retest 
reliability (Gélinas et al., 1996).  In a systematic review of activities of daily living scales 
(ADL), the DAD was thought to be of moderate quality and thought to have good 





When the study was designed and planned there was one study examining the relationship 
between awareness using the MARS on patient Quality of life and used the BASQUID 
measure (Trigg et al., 2011).  It reported a large effect size (f2=0.66). Using Gpower 3 
(Faul et al., 2007), it was calculated that for a multiple regression model with seven 
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predictor variables with an α -level set at 0.05 and power set at 0.80;  that 30 participant 
dyads would need to be recruited in order to detect a large effect size. 
Subsequently there have been more studies published examining the relationship and have 
found  a range of effect sizes smaller than the one reported in the Trigg et al (2011) paper 




Pearson r correlations were conducted on demographic and predictor variables to test for 
multicollinearity and explore potential associations of variables with QoLp and QoLc. No 
evidence of potential multicollinearity was found (Correlations >0.8) between any of the 
variables and therefore it was considered appropriate for all variables to be used 
independently.  
In order to test the hypothesis that awareness of MF and caregiver ratings predict QoLp, 
an initial stepwise hierarchical multiple regression model with patient rated QOL as the 
criterion variable and PwD related variables as predictor variables (self-rated depression 
(HADSDp), neuropsychiatric symptoms (NPIQ-total), Memory functioning discrepancy 
(MFD), and anxiety (HADSAp)) was conducted. A second stepwise hierarchical 
regression model was conducted with the caregiver related variables as predictors 
(Relationship quality (BRSS), caregiver burden (ZBI), caregiver depression and anxiety 
(HADSDc and HADSAc) and caregiver psychological wellbeing (WHQOLpsyc)). The 
significant predictors from each models were then combined into a final QoLp model. 
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In order to test the hypothesis that awareness of MF and caregiver ratings predict QoLc, 
the same methodology was employed with QoLc as criterion variable and PwD related 
variables (activities of daily living (DAD), Neuropsychiatric symptoms (NPIQtotal), was 
conducted. Followed by a second stepwise hierarchical regression model with caregiver 
related variables as predictors (Relationship quality (BRSS), caregiver burden (ZBI), 
caregiver depression and anxiety (HADSDc and HADSAc) and caregiver psychological 
wellbeing (WHQOLpsyc)). The significant predictors from each models were then 
combined into a final QoLc model. 
A backwards regression model will also be conducted examining whether awareness of 
memory function and factors found to associate with caregiver QoL predicts caregiver 
QoL.  




The data was examined for missing items and Little’s missing completely at random 
(MCAR) test was conducted for each of the measures with missing data, all the missing 
items were found to be MCAR. One ZBI case had over 30% of the data missing and so 
omitted from the analysis. One participant refused to answer some of the MARSA tasks 
and one refused to answer some of the ACE-R items and so those individual cases were 
also excluded from the analyses. The missing data was addressed using individual mean 
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imputation  which has been demonstrated to be robust when dealing with limited amounts 









The study sample consisted of 27 people with dementia and their caregivers. The mean 
age of PWD were 78.9 (SD 6.54) and caregivers mean age was 74.8 (7.94). Nine patients 
were women and 20 caregivers were women. Twenty-five were Spouses and two were 
children of PWD. A total of 26 caregivers lived with the PWD. The scores on the ACE-R 










Gender 9 female, 18 male 
Education level 15 I, 3 II, 2 III, 5 IV, 2 V 
Diagnosis 20 AD, 7 mixed AD/VaD 
ACE-R (N=26) (MMSE) 70.11(23.26) 
Caregivers 
 
Age  74.86 
Gender 20 female, 7 male 
Education level 13 I, 2 II, 6 III, 5 IV, 1 V 
Relationship to PwD 25 Spouse, 2 adult child 
Living with PwD 26 Yes, 1 no 
PwD, People with dementia, AD Alzheimer’s disease VaD Vascular dementia; MMSE, 
Mini-Mental State Examination; VaD vascular dementia; Alzheimer's disease; 
Education levels; I, high school; II Trade certificate; III College Diploma; IV University 






Descriptive statistics  
 
The mean PwD’s ratings of QOL (39.93 SD 5.48) were higher than mean caregiver’s 
ratings (33.04 SD 5.87). This difference in means was found to be statistically significant 
(df=52 t=4.46 p<0.0001).  Similarly, PwD rated their memory functioning (44.41 SD 
8.72) higher than their caregiver’s (33.78 SD 10.18) did and this difference in means was 
also found to be significant (df=52 t=4.121 p<0.0001).  There was no significant 
difference in the awareness (MFD) between those diagnosed with AD and those diagnosed 




2Table. 2 Descriptive Statistics 
 Mean Std. Deviation Range 
QOLADp 39.93 5.48 31-50 
QOLADc 33.06 5.86 23-44 
MF PwD 44.41 8.72 15-55 
MF Caregiver 34.30 10.59 17-54 
MFD 0.27 0.39 -0.87-0.95 
MPD 3.02 7.35 -10.67-19 
HADSDp 4.41 3.61 0-14 
HADSAp 5.00 3.16 0-12 
HADSDc 4.22 3.14 0-13 
HADSAc 7.00 4.14 0-16 
NPIQtotal 15.67 20.63 0-104 
DAD 0.75 0.15 0.48-1 
BRSS 31.52 11.01 2-42 
ZBI (N=26) 30.95 13.65 6-67 
WHOQOL-PH 64.57 16.90 30.4-88 
WHOQOL-PSY 68.30 13.59 31-88 
WHOQOL-ENV 75.56 13.47 31-100 
WHOQOL-QOL item 3.89   0.70 2-5 
WHOQOL- Health item 3.70 0.82 2-5 
Abbreviations: QOLAD, Quality of life Alzheimer’s Disease; p, person with dementia; c, 
caregiver; MFD, Memory functioning Discrepancy; MPD, Memory Performance Discrepancy; 
HADS, Hospital Anxiety and Depression Scale, A, Anxiety, D, Depression; NPIQ, 
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Neuropsychiatric symptoms Inventory Questionnaire; Disability Assessment for Dementia; 
BRSS, Burns Relationship Satisfaction Scale; WHOQOL, World Health Organisation Quality of 
Life, PH, Physical Health, PSY, Psychological, SR, Environment, Overall quality of life item, 




The bivariate correlations (Pearson’s r) of variables are presented in Table 3. Neither 
measure of awareness was found to correlate with patient rated QOL-AD (QOL-ADp) 
(MFD r=0.107 p=0.594, MPD r=0.140 p=0.505) nor caregiver rated Qol-AD (QOL-ADc) 
(MFD r=-0.156 p=0.472, MPD r=0.0.025 p=0.439). Although patients’ assessment of 
their memory functioning was found to be significant associated with QOL-ADp (r=-
0.552 p=0.003). Patient rated and caregiver rated QOL were not found to be significantly 
correlated (r=0.351 p=0.085). 
Patient depression and anxiety (HADSp) were found to significantly negatively correlate 
with QOL-ADp (r=-0.689 p<0.0001, r=-0.605, p<.0001 respectively).  QOLP was found 
to significantly negatively correlate with NPI-Q total score (r=-0.489 p=0.01) and ZBI 
caregiver burden (r=-0.547 p=0.006) and positively correlate with relationship quality 
(r=0.492 p=0.009).  None of the WHOQOL subscales were found to correlate with 
QOLD-ADp. WHOQOL psychological wellbeing was found to negatively correlate with 
ZBI (r=-0.547 p=0.006) and HADSp depression (r=-0.547 p=0.006) and positively 
correlate with BRSS caregiver rated quality of relationship (r=-0.547 p=0.006) which all 
were found to significantly correlated with QOL-ADp. It was therefore decided to enter 
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it into the caregiver variable QoLp regression model.  There does not seem to be any 
indication of multicollinearity between the variables as all correlations are below 0.8.  
QOL-ADc was found to significantly positively correlate with DAD activity limitation 
(r=0.691 p<0.0001), and BRSS relationship quality (r=0.516 p=0.006) It was found to 
negatively correlate with ZBI caregiver burden (r=-0.539 p=0.004) and NPI-Q total score 
(r=-0.499 p=0.008). 
The two measures of awareness (MFD and MPD) were found to correlate with each other 
(r=0.550 p=0.004). MFD was found to negatively correlate with depression (r=-0.497 
p=0.008). Caregiver ratings of PwD MF were found to positively correlate with PwD 
performance on memory functioning tasks (r=-0.574 p=0.002). 
BRSS and the WHOQOL overall QoL item were found to significantly correlate (r=-
0.644 p<0.0001) 
No demographic variables were found to significantly correlate with QoLp or QoLc 
 Partial correlations were conducted with ACE-R as a control variable to examine whether 
severity of cognitive impairment had an impact upon associations between variables. 
There was no change in significance between any of the partial and bivariate correlations 












acedemic Carer gender Diagnosis MFSpatient MFScarer MFDcorrected MFtasks MPD HADSAp HADSDp HADSAc HADSDc QOLADp QOLADc
QOLAD 











Participant age 1 -0.106 -0.023 0.26 0.138 -0.091 0.099 0.3 -0.06 0.215 -0.129 0.316 -0.27 -0.101 0.106 -0.125 0.322 -0.221 .520** -0.169 -0.056 -0.047 0.046 -0.062 -0.167 -0.036 -0.083 0.127 -0.178 -0.103 0.2 0.01
Gender 1 0.11 0.097 -.418* -.756** -0.12 -0.122 -.501** 0.372 -0.295 0.354 0.051 0.126 0.329 0.102 -0.273 -0.114 -0.128 -0.06 -0.067 -0.184 0.234 -.417* 0.01 0.133 0.128 -0.123 -0.279 -0.125 -0.115 0.13
Acedemic performance 1 0.232 0.343 0.083 -0.106 0.355 0.231 0.028 0.184 0.213 -0.109 -0.09 -0.11 -0.234 0.151 0.028 0.075 .437* .509** 0.262 -0.033 -0.153 0.102 0.149 0.138 0.124 0.022 0.229 -0.063 0.125
Carer age 1 -0.044 0.307 0.109 0.173 0.2 -0.062 -0.104 0.117 -0.118 -0.143 0.048 0.011 0.358 -0.084 .384* -0.216 -0.283 0.11 -.456* -0.059 -0.121 -0.132 -0.194 -0.096 -0.022 -0.233 -0.079 -0.201
Carer Acedemic 1 0.316 0.029 0.19 0.31 -0.19 0.19 0.019 -0.018 -0.051 -0.124 -0.168 0.065 -0.062 0.102 .401* .521** 0.174 0.252 0.083 0.205 0.274 0.231 -0.192 0.235 .406* 0.233 0.167
Carer gender 1 0.09 0.162 .490** -0.355 0.303 -0.29 -0.144 -0.212 -.439* -0.241 .389* 0.103 0.222 -0.066 -0.164 0.239 -.436* .395* -0.048 -0.119 -0.141 0.035 .436* 0.112 -0.043 -0.135
Diagnosis 1 0.051 0.17 -0.096 0.191 -0.078 0.136 0.194 -0.063 -0.125 -0.165 -0.228 0.127 -0.166 0.094 -0.276 0.029 0.026 0.213 0.055 0.102 0.051 0.177 -0.185 0.096 0.008
MFSpatient 1 0.095 .549** -0.123 .564** -.665** -.684** -0.271 -0.335 .552** 0.088 .383* 0.17 0.262 0.032 -0.222 0.063 -0.175 -0.13 -0.093 0.211 0.284 0.13 0.204 0.328
MFScarer 1 -.761** .574** -0.272 0.005 0.032 0.007 0.23 0.268 0.349 -0.081 .382* 0.386 .536** -0.228 0.242 -0.195 -0.225 -0.186 0.231 -0.052 0.062 0.051 -0.122
MFDcorrected 1 -.531** .550** -.413* -.497** -0.134 -0.355 0.144 -0.156 0.251 -0.195 -0.107 -0.357 0.002 -0.163 0.006 0.043 0.052 -0.011 0.212 0.006 0.117 0.347
MFtasks 1 -.567** 0.191 0.104 -0.049 0.188 0.084 0.133 -0.049 .544** .484* .504** -0.097 0.128 0.013 -0.055 -0.021 -0.003 -0.042 -0.132 -0.189 -0.244
MPD 1 -0.357 -0.251 0.061 -0.272 0.223 0.025 0.171 -0.231 -0.045 -0.174 0.098 -0.188 -0.237 -0.062 -0.078 -0.029 -0.088 0.06 0.181 0.311
HADSAp 1 .802** 0.134 0.24 -.640** -0.039 -.477* -0.151 -0.047 -0.027 0.203 -0.039 0.363 0.27 0.219 -0.317 -0.292 0.016 -0.209 -0.354
HADSDp 1 0.201 0.219 -.719** -0.252 -0.331 -0.186 -0.055 -0.283 .426* -0.122 0.326 0.295 0.212 -0.126 -.422* -0.044 -0.165 -.385*
HADSAc 1 .736** -0.263 -0.035 -0.203 0.078 0.079 0.07 0.298 -.540** -0.176 -0.058 -0.109 0.011 -.759** -0.254 -0.371 -0.011
HADSDc 1 -0.198 -0.074 -0.095 0.157 0.023 0.044 0.282 -.543** 0.076 0.035 0.049 -0.153 -.725** -.478* -.514** -.479*
QOLADp 1 .396* .467* 0.047 -0.014 .430* -.585** .389* -.545** -.510** -.489** 0.046 0.227 -0.04 0.31 0.021
QOLADc 1 -.619** 0.099 0.211 .691** -.539** .516** -.613** -.544** -.499** 0.178 0.155 0.375 .480* 0.333
QOLADdiscrepancy 1 -0.11 -0.233 -0.313 0.021 -0.144 0.121 0.074 0.052 -0.117 0.042 -0.376 -0.155 -0.313
MMSE 1 .832** .412* 0.06 -0.06 0.079 0.105 0.153 0.042 -0.037 0.04 -0.066 0.146
ACER 1 0.349 0.12 0.02 0.034 0.015 0.056 0.138 0.016 0.238 0.266 0.325
DAD 1 -.548** 0.286 -.509** -.383* -0.361 0.144 0.046 0.193 0.128 0.17
ZBI 1 -.551** .621** .665** .651** -0.124 -.419* -0.01 -0.252 -0.058
BRSS 1 -.426* -.526** -.549** 0.069 .526** .425* .644** 0.2
NPIQseverity 1 .860** .874** -0.223 -0.012 -0.064 -0.328 -0.265
NPIQdistress 1 .970** -0.065 -0.107 0.028 -0.357 -0.081
NPIQtotal 1 -0.038 -0.042 -0.014 -0.337 -0.06
WHOQOLphyshealth 1 -0.004 0.154 0.203 .445*
WHOQOLpsyc 1 .466* .450* .414*
WHOQOLsocialrel 0.22 0.275 0.06
WHOQOLEnvironment 1 .489** .622**
WHOQOLQOL 1 .476*
WHOQOLPHitem 1
** Correlation is significant at the 0.01 level (2-tailed).
* Correlation is significant at the 0.05 level (2-tailed).
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Abbreviations QOLAD, Quality of life Alzheimer’s Disease; p, person with dementia; c, caregiver; MFD, Memory functioning Discrepancy; MPD, 
Memory Performance Discrepancy; HADS, Hospital Anxiety and Depression Scale, A, Anxiety, D, Depression; NPIQ, Neuropsychiatric symptoms 
Inventory Questionnaire; Disability Assessment for Dementia; BRSS, Burns Relationship Satisfaction Scale; WHOQOL, World Health Organisation 
Quality of Life, PH, Physical Health, PSY, Psychological, SR, Social Relationships, Environment   
Significance are included to present the data fully and indicative only as they have not been corrected for multiple comparisons. 
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Person with Dementia rated Quality of Life regression model 
 
Person with Dementia variables 
The data met the assumption of independent errors (Durbin Watson= 1.8) and there did 
not seem to be a suggestion of multicollinearity as tolerance scores were above 0.2 and 
Variance inflation factor scores (VIF) were below 10. No outliers were found. The data 
for the model is presented in Table 3. 
QOLADp was significantly predicted by a model containing PwD rated HADSp 
depression and NPIQ total score (F2,24=20.894, p<0.0001, adjusted R
2=0.605), with both 
variables individually significant. MFD and HADSp Anxiety were added in subsequently 
into the model but did not contribute significantly to the variance and were not 
individually significant. Increases in QOLADp were associated with decreases in 
depressed mood and Neuropsychiatric symptoms. The observed statistical power of the 
model was 0.999.  
In order to further investigate the relationship of awareness of memory functioning to 
QOLADp an additional model was conducted with PwD ratings of MF being added to the 
model instead of MFD. No additional variance was explained and PwD ratings of MF 
were found to be a significant predictor.   
 
As mood is a component of QoL and the QOLAD and therefore is redundancy between 
the measures, inter-item correlations were conducted on the HADSDp and QOLADp. 
Significant negative correlations were found between a number of items and not just the 
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QOLAD Mood item which would suggest that the relationship demonstrated is not just 
an artifact of measuring the same construct. 
 
Caregiver variables 
A second hierarchical stepwise regression model was conducted exploring the variance 
explained by the caregiver variables (Table. 3). The data met the assumption of 
independent errors (Durbin Watson= 2.4) and there did not seem to be a suggestion of 
multicollinearity as tolerance scores were above 0.2 and VIF were below 10.  
QoLADp was significantly predicted by a caregiver variable model containing ZBI 
caregiver burden and BRSS caregiver rated relationship quality (F2,23=6.141, p=0.007, 
adjusted R2=0.291), When entered individually BRSS was a significant predictor but once 
ZBI was entered into the model it no longer became significant while ZBI was a 
significant predictor. Caregiver HADS anxiety, HADS depression, and WHOQoL-Bref 
psychological subscale was added subsequently but did not contribute significantly to the 
variance explained. Increases in QoLADp were associated with decreases in ZBI 
caregiver burden. The observed statistical power of the model was 0.898. 
 
Combined model 
The two QoLADp models were then combined and ZBI caregiver burden was then added 
to the previous research model (Table 3). QoLp was significantly predicted by HADSp 
depression and NPIQ total score (F2, 24=19.593, p<0.0001, adjusted R
2=0.598). Both with 
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individually significant predictors. Adding ZBI caregiver burden to the model did not 




4Table 4. Regression analyses Beta and p-values for predictors of QOLADp and adjusted    












Adjusted R2  0.601  0.291  0.598  
 
beta p beta p beta p 
HADSDp -0.644 <0.0001 
  
-0.624 <0.0001 





-0.532 0.015 - - 
 
Caregiver rated PwD Quality of Life regression model 
 
Person with Dementia variables 
The data met the assumption of independent errors (Durbin Watson= 1.4) and there did 
not seem to be a suggestion of multicollinearity as tolerance scores were above 0.2 and 
VIF were below 10. The data for the model is presented in Table. 5 
QOLADc was significantly predicted by a model containing DAD activities of daily living 
(F1,24=20.724, p<0.0001, adjusted R
2=0.441)., NPIQ total score, and MFD were added in 
subsequently into the model but did not contribute significantly to the variance and were 




The data met the assumption of independent errors (Durbin Watson= 2.19) and there did 
not seem to be a suggestion of multicollinearity as tolerance scores were above 0.2 and 
VIF were below 10. QOLADc was significantly predicted by model (Table. 4) containing 
ZBI caregiver burden and BRSS relationship quality (F2,23=8.262, p=0.002, adjusted 
R2=0.367). HADSc anxiety and depression, and WHOQOL psychological were 
subsequently added to the model but did not significantly contribute to the variance of the 
model and were not individually significant. The observed statistical power of the model 
was 0.926. 
Combined model 
 QOLADc was significantly predicted by a model containing DAD activities of daily 
living and BRSS caregiver rated relationship quality (F2,23=16.452, p<0.0001, adjusted 
R2=0.553). Increases in QOLADc was associated with increases in DAD activities of 







5 Table. 5 Regression analyses, Beta and p-values for predictors of QOLADc and 
adjusted R2 values for each model. 
 
Models PwD variables Caregiver Variables Final model 
Adjusted R2  0.441  0.367  0.553  
 beta p-value beta p-value beta p-value 
DAD 0.691 <0.0001   0.592 <0.0001 
ZBI   -0.303 0.126 - - 
BRSS   0.516 0.006 0.347 0.021 
 
 





























Activities of daily 
living 
 













-0.592 Numbers are path coefficients. All path coefficients shown are statistically significant. 
Dotted lines represent non-significant paths.  
 
 
Figure 1. Conceptual model illustrating the predictors of Patient and caregiver rated 
quality of life 
Numbers are path coefficients. All path coefficients shown are statistically significant. 
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Caregiver Quality of Life regression model 
  
The data met the assumption of independent errors (Durbin Watson= 1.1) and there did 
not seem to be a suggestion of multicollinearity as tolerance scores were above 0.2 and 
VIF were below 10. The data for the model is presented in Table. 6.  
WHOQOL-Bref psychological was predicted by a model containing HADSc Anxiety, 
HADSc Depression and HADSp Depression (F1,21=17.094, p<0.0001, adjusted 
R2=0.0.659). HADSp depression was not an individually significant predictor. BRSS, 
ZBI, and MFD were removed from the final model.   Increases with WHOQOL 
psychological wellbeing were associated in decreases with HADS Caregiver anxiety and 
HADS caregiver depression. The observed statistical power of the model was 0.999.    
 
 
6Table. 6 Regression analyses, Beta and p-values for predictors of WHOQOL-Bref 
psychological subscale. 
 beta p-value 
HADSAc -0.470 0.012 
HADSDc -0.323 0.043 










Awareness of Memory functioning and PwD rated Quality of life  
 
The results of the study do not support the hypothesis that awareness of memory 
functioning and caregiver related factors are predictive of QoLp. Depression and of 
neuropsychiatric symptoms total score were the only variables found to be predictive of 
QoLp, with decreases in both leading to increases in QoLp. The finding that awareness, 
at both the evaluative judgement level and performance monitoring level was not 
predictive of QOLp in a model including depression was consistent with the most 
comprehensive examination of awareness and factors that predict QoLp (Woods et al., 
2014). A similar level of variance was also explained as their model and although non-
significant the bivariate correlation between MFD and QoLp in the study (-0.144) was not 
much lower than the significant one reported by Woods et al. (2014) (-0.21). The lack of 
relationship with evaluative judgement awareness of memory function and QoLp appears 
to not be consistent with Trigg et al. (2011) and Conde-Sala et al. (2014) findings. These 
studies did not use the corrected discrepancy score described in (Clare et al. (2010) but 
rather used simple discrepancies which weight the scores more in favour of the caregiver 
ratings.  The Trigg et al. finding was with a different measure of quality of life which may 
account for the differences found. Conde-Sala et al used a more general measure of 
awareness (Migliorelli et al., 1995b) which includes items on functional and behavioural 
changes as well as memory functioning which may have a different relationship to QoLp. 
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The lack of relationship between memory performance awareness and QoLp is consistent 
with previous findings (Woods et al., 2014). This may be because task-specific errors on 
memory performance tasks can be dismissed or rationalised as a normal part of aging and 
so do not affect PwDs appraisals of their memory or impact upon their QoL(Clare et al., 
2011a).  
A negative association between the evaluative judgement  measure of awareness of MF 
(MFD) and depression was found consistent with the literature (Clare et al., 2012a), as 
was the negative association found between depression and QoLp. However, no direct 
association was found between awareness of MF and QoLp. Recent studies that have 
demonstrated that depression mediates the relationship between awareness of memory 
functioning and depression (Cines et al., 2015; Woods et al., 2014). These findings 
suggested that people with high awareness are only more likely to report low QoL if their 
mood is low. These findings would mean that an association between awareness of MF 
and QoLp would still be expected to be found in this study which it was not. The 
significant association found in those studies was a small effect so it may be that the 
sample size used here was not large enough to detect it. If the PwD ratings of their memory 
functioning are used rather than a discrepancy score of PwD and Caregiver ratings, then 
a direct association is found between those ratings and QoLp as well as a negative 
association with depression. This would suggest that the important factor is whether the 
PwD has a positive or negative appraisal of their MF as this does affect their ratings of 
their QoL while the accuracy of the PwD’s appraisal of their MF does not affect ratings 
of their QoL. This would seem to fit with recent findings suggesting awareness of MF 
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relationship to QoLP is driven by level of depression. If PwD’s mood is low then they are 
more likely to appraise their memory as worse and report lower QoL.  
 
It may be that the association between unawareness of MF and depression is actually two 
dffierent effects.  It has been argued that unawareness is a psychological reaction to 
impairment in memory functioning (Migliorelli et al., 1995b) in sub-clinical depression 
and PwD overestimate their ability to as a form of coping/avoidance with their low mood 
and distress. It has also been suggested that those who met criteria for depression rate their 
MF more negatively or conservatively than those with better mood (Nakaaki et al., 2008) 
(underestimate their functioning). This is in line with the negative attribution bias 
commonly found in depression. Both of these positions highlight how appraisals of MF 
and thus evaluative judgement awareness are affected by depression although it seems 
that there are potentially two different awareness processes associated in a similar 
direction with depression. The mean awareness of MF combined with the low level of 
depression in this study would suggest that the sample as a whole overestimated their 
abilities supporting the notion of unawareness of MF being a psychological reaction to 
protect them from distress around their difficulties. However, there were a few 
participants in the sample that scored in the clinical range for depression that 
underestimated their abilities to a large degree. No firm conclusions can be drawn from 
this but it warrants further investigation as it potentially could be a separate effect. From 
clinical experience those with high levels of depression in this population report the most 
severe impairment in terms of memory functioning.  Most studies in the literature have 
examined samples that predominantly overestimate their MF and have subclinical levels 
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of depression. Further research is needed to examine overestimation and underestimation 
separately and investigate whether they have differing relationships to clinical and 
subclinical depression. 
 
Caregiver variables and PwD Quality of Life 
 
The caregiver related variables were not found to explain any further variance in PwD 
QoL model. Caregiver psychological wellbeing was not found to be a predictor nor 
correlated with QoLp. Caregiver rated relationship quality initially predicted QoLp when 
entered into the model alone with better relationship quality leading to increases in QoLp 
but the variance it explained was accounted for better by caregiver burden. Caregiver rated 
relationship quality not being a significant predictor of QoLp is consistent (Clare et al., 
2014) findings.  When caregiver burden was entered into the final model with self-rated 
depression and impact of NP symptoms it was no longer a significant predictor. This 
would suggest that the variance explained by caregiver burden in relation to QoLp was 
better accounted for by the PwD’s mood and impact of NP on PwD and caregiver.  
Caregiver burden was significantly correlated with severity of NP and distress 
experienced sub-scales of the NPI-Q. It makes sense that there is a great deal of shared 
variance among the measures as they both focus on the response to difficult experiences 
in the caregiving context and the caregiver’s response to that. The fact that these caregiver 
focussed variables can be found to explain variance relating to QoLp supports the notion 
that PwD have an awareness of their caregivers’ emotional state and attitude and that this 
has an impact upon them as has been suggested previously (Ablitt et al., 2010; Woods et 
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al., 2014). However, the model suggests that the impact of their caregiver’s emotional 
state on PwD QoL is best accounted for by the way it affects the PwD level of depression 
rather than being a separate factor.  
 
Predictors of PwD rated Quality of life 
 
 Whilst the hypotheses in relation to QoLp was not confirmed, the QoLp was able to 
provide further evidence for the role of depression and impact of neuropsychiatric 
symptoms in predicting QoLp with increased depression and neuropsychiatric symptoms 
being associated with worse QoLp. Consistent with the literature depression emerged as 
the strongest predictor of self-reported QoL. There is a low level of depression reported 
in the sample but it is consistent with the level found in other samples in the literature 
(Cines et al., 2015; Clare et al., 2010; Woods et al., 2014). While mood is conceptualised 
as part of QoL the item by item correlations conducted between the depression and QoLp 
measures demonstrated that it is not simply an artefact of measuring the same construct. 
The consistent finding of depression predicting QoL highlights the importance of 
professionals screening for low mood in PwD.  
 It has been suggested that multivariate analyses studies tended to confirm behavioural 
disturbance and affective symptoms as predictors of QoL (Banerjee et al., 2009) and this 
finding was furthered in this study. This study has a small sample size but the large amount 
of variance accounted for by the model, the strong observed power of the model, and 
consistency of the findings with the research literature means it can be stated with 
confidence that depression and neuropsychiatric symptoms predict QoLp. However, it 
108 
 
should be noted that some variables that have recently been demonstrated to predict QoLp 
were not included in the study (self-concept and PwD rated relationship quality) and it 
may be that those variables would explain additional variance or better explain some of 
the variance accounted for in this model.      
   
Caregiver rated Quality of life for the PwD they care for 
 
The second research hypothesis regarding caregiver rated QoL was also mostly 
disconfirmed. It would seem that Caregiver’s perceptions of PwD QoL are driven by how 
functionally able they are how they are able to maintain their relationship with the 
caregiver. Activity limitation was found to be the strongest predictor of QoLp entirely 
consistent with previous research (Conde-Sala et al., 2014; Naglie et al., 2011b; Orgeta et 
al., 2015). Caregiver rated quality of relationship was also found to be a significant 
predictor with increases in caregiver perceived relationship quality leading to increases in 
QoLc. Awareness of MF, caregiver QoL and wellbeing, were not found to be predictors 
of QoLc. This is the first time that caregiver rated relationship quality has been 
investigated in predicting QoLc and represents a new and important finding. This finding 
provides further evidence to the importance of the caregiver relationship in the caregiver 
context. High relationship quality has already been found to be associated with low 
caregiver burden, better care provided by caregiver, and better caregiver wellbeing (Quinn 
et al., 2009; Steadman et al., 2007). This would seem to suggest that the caregiver related 
variables hypothesised to be predictive of QoLc are best understood in the QoL context 
in terms of caregiver relationship quality. This finding is borne out by clinical experience 
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as those with the most supportive caregiver relationships seemed to be report the highest 
functioning and QoL.  There is still much to be understood around this finding. As current 
relationship quality was measured it is not clear to what extent it is a factor of premorbid 
relationship quality. The sample was also majority spousal caregivers, further 
investigation is need to examine whether this effect would be found in adult children 
caregivers.  The significant predictors found for QoLc in this study reinforces further the 
notion that PwD and their caregivers rate PwD’s QoL differently and it is therefore 
important to explore both perspectives when planning a clinical intervention to improve 
PwD QoL  
 
Predictors of Caregiver Quality of life 
 
The hypothesis to the secondary research question that awareness of memory functioning 
would predict affected caregiver QoL was not confirmed by this sample. The 
psychological wellbeing subscale of the WHOQOL was found to be predicted by 
caregiver anxiety and depression which would be expected as that is broadly what the 
measure examines and so provides little additional insight into the construct. PwD 
depression emerged as a non-significant predictor. It was found to correlate with caregiver 
burden and relationship quality but they were not significant predictors suggesting that 
the association is better accounted for by the significant predictor variables. As this 
investigation was only a subscale it does not present a holistic picture of caregiver QoL. 
There were no significant associations between study variables and the other subscales to 
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guide further analysis. The overall QoL item was associated with relationship quality 
further asserting the importance of the caregiving relationship. 
 
Measuring and Sampling issues 
 
The partial correlations conducted with level of cognitive impairment controlled for and 
the lack of associations between the measures of cognitive impairment and study measures 
would suggest that the level of cognitive impairment was not related to the results found. 
This is consistent with previous findings (Banerjee et al., 2009; Trigg et al., 2011; Woods 
et al., 2014). While the measures used would have accommodated a more moderate 
dementia sample, the majority of the PwD examined in the sample would be considered 
to have a mild level of cognitive impairment consistent with early-stage dementia. This 
was due to the convenience sampling nature of recruitment. The sample is comparable 
with other samples in the literature as they tend to be early/ mild dementia and recruited 
from memory clinics using a conveniences sample methodology.    
There are currently no studies to directly compare the use of the MARSA but the data 
produced with adjusted Memory functioning scale are comparable to studies that have 
used the Memory functioning scale (Clare et al., 2012a, 2010). The memory functioning 
discrepancy and memory performance discrepancy were significantly correlated which 
would seem to suggest that the caregivers were accurately rating their PwD memory 
functioning and that the two scales are measuring the same construct. This strength of 
correlation was not found in development of the measure (Hardy et al., 2006). This 
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difference may be due to using the corrected discrepancy score described in (Clare et al., 
2010). 
This study examines awareness in domain of memory functioning and performance. As 
stated previously, awareness is a complex multi-factorial concept and so it is important to 
define the nature of awareness studies and acknowledge the results found here in regards 
to awareness cannot be generalised outside the specific  domains of  awareness of memory 
functioning and memory performance awareness in line with recommendations in Clare 
et al. (2005).   
The study sample was very small for a regression analysis, the observed power for the 
produced models and large effect size found would suggest that those models are 
adequately powered and those positive findings can be considered robust. However, the 
non-significant findings of the variables that did not fit into the final models should be 
treated with caution and it cannot be ruled out that the sample size was not big enough to 
detect those effects and there is possibility of Type II errors.        
The study was cross-sectional in design so direct causation about any of the relationships 
presented cannot be determined.  Mood and Neuropsychiatric symptoms are variables that 
can fluctuate within individuals and may fluctuate frequently and may fluctuate over time 
so it would important to examine these findings in a longitudinal study. Further research 
is needed to examine how these factors change over time. One recent study has found that 
QoLp at twenty is significantly predicted by baseline QoLp and quality of caregiving 
relationship (Clare et al., 2014).   
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This study’s sample was a homogenous, mostly white male sample of PwD and their 
female spousal caregivers living in Scotland. The majority of the sample would be 
considered to be in early stage dementia.  These factors should be acknowledged when 
considering the generalisability of the findings of this study. The findings reported here 
should also be considered to be only generalizable to family caregivers who are living 
with PwD. They are also only generalizable to spouse caregivers as the sample here was 
almost exclusively spouses. Spouse caregivers have been demonstrated to have different 
perceptions to other family caregivers. Spouse caregivers are more likely to have more 
positive perceptions of PwD QoL while adult children had more negative perceptions of 
PWD QoL which were associated with greater caregiver burden and higher levels of 
depression in the patient. Daughter caregivers’ negative perception of QoL showed the 





This study did not find that awareness of memory functioning predicted either PwD or 
Caregiver QoL. Although PwD ratings of their memory functioning were found to be 
associated with QoLp most likely as a function of PwD level of sub-clinical depression. 
None of the caregiver related variables examined were found to be predictive of PwD 
rated QoL. QoLp was found to be negatively influenced by the level of PwD depression 
and the impact of neuropsychiatric symptoms. Caregiver burden was found to be 
associated with QoLp but its relationship was better accounted for by PwD depression 
113 
 
and neuropsychiatric symptoms. Caregiver ratings of PwD QoL were demonstrated to be 
influenced by the ability of the PwD to complete daily activities of living and the 
caregiver’s perceptions of the quality of the relationship with PwD. This supports the view 
that PwD and caregivers appraise different factors when rating PwD QoL and multiple 
perspectives should be considered when assessing PwD QoL. It also furthers the 
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Appendix A: Reason for exclusion from Meta-analysis. 
 
Study Reason for Exclusion 
Arkin et al 2001 Awareness measure did not meet inclusion criteria 
Boyars et al 2014 Awareness measure did not meet inclusion criteria 
Burke et al 1998 Awareness measure did not meet inclusion criteria 
Chen et al 2012 Awareness measure did not meet inclusion criteria 
Conde sala et al 2014 same sample as study already included in analysis 
Debettingnes et al 1990 Awareness measure did not meet inclusion criteria 
Derouesne et al 1999 Awareness measure did not meet inclusion criteria 
Lin et al 2010 Awareness measure did not meet inclusion criteria 
Maki et al 2012 Association not assessed 
Michon et al 1994 No data reported 
Mograbi et al 2012 Awareness measure did not meet inclusion criteria 
Padoani et al 2001 No data reported  
Reed et al 1993 No data reported 
Rocca et al 2010 Unable to compute effect size 
Satler 2013 No data reported 
Seiffer et al 2005 No data reported 
Seltzer et al 1995 Unable to obtain article 
Sevush and Leve 1993 No data reported 
Sousa et al 2015 Same sample as study already included in analysis 
Spaletta et al 2012 Depression measure did not meet inclusion criteria 
Triosi et al 1996 Awareness measure did not meet inclusion criteria 
Van Viliet et al 2012  Unable to compute effect size 
Vasterling et al 1997 Depression measure did not meet inclusion criteria 
Vogel et al 2005  Depression not assessed 
Vogel et al 2014 same sample as study already included in analysis 
Waldorff et al 2010 same sample as study already included in analysis 
Waldorff et al 2014 same sample as study already included in analysis 
Woods et al 2014 same sample as study already included in analysis 
































Appendix D. Distribution Data of study and demographics variables 
 
 
Skewness  Kurtosis 
 
Statistic Std. Error Statistic Std. Error 
MFSpatient -1.465 .448 3.579 .872 
MFSCaregiver .099 .448 -.712 .872 
MFDcorrected -.636 .448 1.617 .872 
MFtasks -.105 .448 -.798 .872 
MPD .118 .456 -.181 .887 
HADSAp .985 .448 .218 .872 
HADSDp 1.181 .448 1.344 .872 
HADSAc .394 .448 -.530 .872 
HADSDc 1.233 .448 1.943 .872 
QOLADp -.046 .448 -.654 .872 
QOLADc .054 .448 -.903 .872 
QOLADdiscrepancy .334 .448 1.028 .872 
MMSE -.384 .448 -.307 .872 
ACER -.368 .456 -.704 .887 
DAD .021 .448 -.891 .872 
ZBI .532 .456 .860 .887 
BRSS -1.533 .448 1.765 .872 
NPIQseverity 1.154 .448 1.789 .872 
NPIQdistress 2.604 .448 9.433 .872 
NPIQtotal 3.199 .448 13.098 .872 
WHOQOLphyshealth -.552 .448 -.231 .872 
WHOQOLpsyc -.722 .448 .545 .872 
WHOQOLEnvironment -1.124 .448 3.667 .872 
WHOQOLQOL -.579 .448 1.102 .872 
WHOQOLPHitem -.716 .448 .319 .872 
QOLAD, Quality of life Alzheimer’s Disease; p, person with dementia; c, caregiver; MFD, 
Memory functioning Discrepancy; MPD, Memory Performance Discrepancy; HADS, Hospital 
Anxiety and Depression Scale, A, Anxiety, D, Depression; NPIQ, Neuropsychiatric symptoms 
Inventory Questionnaire; Disability Assessment for Dementia; BRSS, Burns Relationship 
Satisfaction Scale; WHOQOL, World Health Organisation Quality of Life, PH, Physical Health, 





















PARTICIPANT INFORMATION SHEET 
  
Awareness in Dementia: How does Insight affect the quality of life for patients and 
caregivers? 
  
We would like to invite you to take part in a research study. Before you decide it is 
important for you to understand why the research is being done and what it will involve 
for you. Please take time to read the following information carefully and discuss with 
others if you wish. Ask us if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part. 
   
Why is the study being done? 
 
Alzheimer's disease can have a large impact on people's lives and on those around them. 
Our study is looking at a part of Alzheimer's disease called insight. If you have insight 
into your illness that means that you are aware that you have it and you know how it 
affects you, some people with Alzheimer’s disease have more insight into their disease 
than others. This study aims to find out if there is any link between the amount of insight 
patients with Alzheimer’s disease have, how well they feel and amount of things they 
need help with. We will also look at how patients and carers feel about their situation 
and other related factors.   
  




We are inviting you to participate because you are receiving care from the Community 
Mental Health Team for Older Adults. Everyone we ask is over 65 years old, has 
Alzheimer's disease and has someone close who knows them well and is happy to be 
interviewed. We asked your doctor to put forward people they thought would be suitable 
and they asked you if you would be agree to us speaking to you about it. We are inviting 
you to take part in an interview with one of the research workers to find out if you are 
eligible for the study.  A total of 60 people will participate in the study. 
  
Do I have to take part? 
 
It is up to you to decide whether or not to take part in the study.  We will describe the 
study and go through this information sheet, which we will then give to you.  We will 
then ask you to sign a consent form to show you have agreed to take part.  You are free 
to withdraw at any time, without giving a reason.  If you decide not to take part, this will 





What will happen to me if I take part? 
 
If you agree you will first take part in an interview with a research worker to find out if 
you are eligible for the study. The interview will take part at a local clinic or in your 
own home   
  
You will be involved in the research for 12 months (the study overall will last for 2 
years). 
  
You will be asked to complete some questionnaires and take part in assessments with 
the research worker at the start of the study, and then complete the same questionnaires 
12 months later.  The research worker will ask about how you have been feeling, how 
you have been coping and any problems you have experienced.  Your caregiver will also 
be asked to complete some similar questionnaires as well. These assessments will take 
approximately an hour each to complete and can be spread over more than one visit 
depending on your preference 
   
What do I have to do? 
 
To enter the study all you need do is to agree to attend the appointments.  These will be 
made to suit your convenience. 
  
What are the disadvantages or risks of taking part? 
 
The assessments involve talking about how you are feeling and seeing how well you can 
do certain tasks.  It may be that this causes some clients discomfort or distress. you will 




What are the possible benefits of taking part? 
 
We hope that the assessments will be interesting and informative for you. However, we 
cannot promise this. As we will not be changing your treatment in any way, any benefit 
you might find will be purely coincidental. The information we get from this study may 
help us to improve the treatment of people with Alzheimer’s Disease in future.  
  
What happens when the research study stops? 
 
Once the study is finished we will make the results available to other health care staff by 
publishing it in a journal and talking about it at conferences. The study should not alter 
your usual treatment. If you are agreeable, the researcher will pass on information about 
things you have helpful or unhelpful during session to health care worker.   




Will my taking part be kept confidential? 
 
All information which is collected about you during the course of the research will be 
kept strictly confidential and will conform to the Data Protection Act of 1998 with 
respect to data collection, storage and destruction.  It will be stored securely on NHS 
premises. When information is used it will be anonymised.  
  
With your permission, your GP will be notified of your participation in the study as will 
your Community psychiatric nurse and psychiatrist.  However, unless there is 
information which puts you or others at serious risk of harm, information collected in 
the study will not be fed back or exchanged without your consent. 
  
We need to assess how your main care giver is coping and so will ask them to complete 
some questionnaires as well. You may decline permission for us to speak to your care 
giver. However, this will mean that you cannot take part in the study. 
   
What will happen if I don’t want to carry on with the study? 
 
You can withdraw from the study completely at any time and this will not affect your 
usual treatment. 
 
Will I get any expenses if Ii take part? 
 
Yes. if you travel to and from the clinic we will refund your travelling expenses.  
 




If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions (see contact number 
below).  If you remain unhappy and wish to complain formally, you can do this through 
the NHS Complaints Procedure.  Details can be obtained from the local hospital. 
  
This study does not involve experimental medications or alter your routine treatment as 
such we do not expect serious adverse events. There are no special arrangements for 
compensation within the study. 
  





We aim to publish the results of the study in a scientific journal but will also make them 
available to all participants in a non scientific format.  We do not expect the results to be 
available until after the end of the study (2016). Some of the results will also be written 





Who is organising and funding the research? 
It is organised by Forth Valley Health Board in partnership with The University of 
Edinburgh. 
  
Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee to protect your safety, rights, wellbeing and dignity.  This study has 
been reviewed and given favourable opinion by a Research Ethics Committee. 
  
Contact for further information 
If you require further information about the study you may contact one of the following 
people: 
  
Dr Vivek Pattan     Tom Weavers 
Consultant Psychaitrist   Trainee Clinical Psychologist/ Research 
worker 
CMHT- Older Adults    CMHT- Older Adults    
Stirling Community Hospital   Stirling Community Hospital 
Livilands Gate    Livilands Gate 
Stirling      Stirling 
FK8 2AU     FK8 2AU    
  
Phone :01786 454 667   Phone: 01786 454 665 
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Thank you for taking time to read this information. 
  
Version 1.1 date 02/12/14 
139 
 







PARTICIPANT INFORMATION SHEET 
Carer Version 
  
Awareness in Dementia: How does awareness of memory symptoms affect the quality of 
life for patient and caregiver 
  
We would like to invite you to take part in a research study. Before you decide it is 
important for you to understand why the research is being done and what it will involve 
for you. Please take time to read the following information carefully and discuss with 
others if you wish. Ask us if there is anything that is not clear or if you would like more 
information. Take time to decide whether or not you wish to take part. 
  
  
Why is the study being done? 
 
Alzheimer's disease can have a large impact on people's lives and on those around them. 
Our study is looking at a part of Alzheimer's disease called insight. If you have insight 
into your illness that means that you are aware that you have it and you know how it 
affects you, some people with Alzheimer’s disease have more insight into their disease 
than others. This study aims to find out if there is any link between the amount of insight 
patients with Alzheimer’s disease have, how well they feel and amount of things they 
need help with. We will also look at how patients and carers feel about their situation 
and other related factors.   
 
Why have I been invited? 
 
We are inviting you to participate because you are the main care giver for someone 
receiving care from the Community Mental Health Team for Older Adults who has a 
diagnosis of Alzheimer’s Disease.  We are inviting you to take part in an interview with 
one of the research workers to find out if you are eligible for the study.  A total of 60 
people will participate in the study. 
  
Do I have to take part? 
 
It is up to you and the person you care for to decide whether or not to take part in the 
study.  You will receive this form in the post and then a researcher will come out to meet 
you and talk you through this information sheet about the study and answer any 
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questions you have.  We will then ask you and your relative/ friend to sign a consent 
form to show you have agreed to take part.  You are free to withdraw at any time,  
 
without giving a reason.  If you decide not to take part, this will not affect the standard 
of care received. If you or the person you care for does not wish to take then the other 
party will be able to take part.  
  
What will happen to me if I take part? 
  
You will be asked to complete some questionnaires and take part in assessments with 
the research worker at the start of the study, and then asked to complete some of the 
same assessments again after 12 months.  The research worker will complete 
questionnaires about how you have been feeling, how you have been coping, the 
behaviour of the person you care for and problems you have experienced.  These 
assessments will take approximately one hour to complete and can be spread over more 
than one visit depending on your preference.  
   
What do I have to do? 
 
To enter the study all you need do is to agree to attend the appointments.  These will be 
made to suit your convenience. 
  
What are the disadvantages and risks of taking part? 
 
The assessments involve talking about how you are feeling and coping and the 
behaviour of you the person you care for.  It may be that this causes some clients 
discomfort or distress. 
  
What are the possible benefits of taking part? 
 
We hope that the assessments will be interesting and informative for you. However, we 
cannot promise this. The information we get from this study may help us to improve the 
treatment of people with Alzheimer’s disease.  
  
What happens when the research study stops? 
 
Once the study is finished we will make the results available to other health care staff by 
publishing it in a journal and talking about it at conferences. The study should not alter 
your usual treatment. If you are agreeable, the researcher will pass on information about 
things you have helpful or unhelpful during session to the health care worker of the 
person you care for.   
  
   





All information which is collected about you during the course of the research will be 
kept strictly confidential and will conform to the Data Protection Act of 1998 with 
respect to data collection, storage and destruction.  It will be stored securely on NHS 
premises. When information is used it will be anonymised.  
  
With your permission, your GP will be notified of your participation in the study as will 
your Community psychiatric nurse and psychiatrist.  However, unless there is 
information which puts you or others at serious risk of harm, information collected in 
the study will not be fed back or exchanged without your consent. You may decline 
permission for us to speak to the person you care for. However, this will mean that you 
cannot take part in the study. 
   
What will happen if I don’t want to carry on with the study? 
 
You can withdraw from the study completely at any time and this will not affect your 
usual treatment.  
  
What if there is a problem? 
 
 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions (see contact number 
below).  If you remain unhappy and wish to complain formally, you can do this through 
the NHS Complaints Procedure.  Details can be obtained from the local hospital. 
  
This study does not involve experimental medications or alter your routine treatment as 
such we do not expect serious adverse events. There are no special arrangements for 
compensation within the study. 
  
What will happen to the results of the research study? 
 
We aim to publish the results of the study in a scientific journal but will also make them 
available to all participants in a non scientific format.  We do not expect the results to be 
available until after the end of the trial (2016). Some of the results will also be written up 
as part of a doctoral thesis. 
  
Who is organising and funding the research? 
 
This study is funded by the National Institute of Health Research. It is organised by 
Forth Valley Health Board in partnership with The University of Edinburgh. 
  
Who has reviewed the study? 
 
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee to protect your safety, rights, wellbeing and dignity.  This study has 




Contact for further information 
If you require further information about the study you may contact one of the following 
people: 
  
Dr Vivek Pattan     Tom Weavers 
Consultant Psychaitrist   Trainee Clinical Psychologist/ Research 
worker 
CMHT- Older Adults    CMHT- Older Adults    
Stirling Community Hospital   Stirling Community Hospital 
Livilands Gate    Livilands Gate 
Stirling      Stirling 
FK8 2AU     FK8 2AU    
  
Phone :01786 454 667   Phone: 01786 454 665 




Thank you for taking time to read this information. 
  
  






Appendix G: Consent form – Patient 
 
PATIENT CONSENT FORM 
 
Awareness in Dementia: How does awareness of symptoms affect the quality of life for 
patient and caregiver 
 
Please tick yes/no & 
initial box 
CONSENT FOR PARTICIPATION IN TRIAL 
 
 
1 I confirm that I have read and understand the information sheet 
dated ............................  (version……) for the above study and have had the 




   
2 I understand that my participation is voluntary and that I am free to withdraw at 





   
3 I understand that data collected during study may be looked at by individuals from 
regulatory authorities or from NHS. I give permission for these individuals to 
access to my records. 
 
YES….NO…. 
   
4 I understand that my GP and my medical consultant will be informed of my 





      
5 I agree to take part in the above study.   
 
                                                 
 
YES….NO…. 
ADDITIONAL CONSENTS  
 
 
   
6 I agree to be contacted again in a years time to see if I am willing to take part in the 






Name of Participant 
 
 











____________________________  ________________________       _________________ 
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Name of Person taking consent 
(if different from researcher) 
Signature Date 
 
Appendix H: Consent form – Caregiver 
 
 
CONSENT FORM for relatives & caregivers  
Awareness in Dementia: How does awareness of symptoms affect the quality of life for 
patient and caregiver 
 
 
CONSENT FOR PARTICIPATION IN TRIAL 
 
                                       Please initial box 
   
1 I confirm that I have read and understand the information sheet 
dated ............................  (version ............) for the above study and have 




   
2 I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my medical care or legal rights or 




   
3 I agree to take part in the above study.                                               
 
YES….NO…. 
      
ADDITIONAL CONSENTS  
 
 
   
   
4 I agree to be contacted again in a years time to see if I willing to take part in the 







________________________ ________________                     ____________________ 
Name of Relative/Friend Signature  Date  
 
 
_________________________ ________________                      ____________________ 
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Researcher Signature  Date   
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Appendix I: Demographic questionnaire 
 










Patient Age......................   Carer age..................... 
 
Patient Probable diagnosis 
 Alzhiemer's Disease 
 Mixed AD/ Vascular 
 Mixed AD/Other.......................... 
 
Patient Marital Status 
 Single (never Married) 
 Married 
 Partnered (other than married) 






Patient Relationship to Carer 
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 Spouse/ partner 
 Sibling 




Patient Highest Academic Achievement                         
 Primary school 
 High School 
 Trade or Technical Certificate 
 College Diploma 
 University degree 
 Post Graduate degree 
 other.................................. 
 
Carer Highest Academic Achievement                         
 Primary school 
 High School 
 Trade or Technical Certificate 
 College Diploma 
 University degree 
 Post Graduate degree 
 other.................................. 
 
Patient Living arrangements 
 living at home (supported by family/ carer or partner) 
 living with family/carer but not own home 
 living alone 
 living in sheltered accommodation 
Other........................................................ 
 






Other patient health needs......................................................................................... 
 
 
Other Carer health needs........................................................................................... 
 
















2. Indian      
3. Pakistani 
4. Bangladeshi 










1. White & Black Caribbean 
2. White & Black African 
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3. White & Asian 
4. White & Chinese 
5. Any other mixed background (please specify) 
_______________________________________ 
 
Other ethnic group 
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